University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

8-1988

A Relationship Between Vitamin B12, Folate, Ascorbic Acid, and
Mercury Metabolism
Nancy Elizabeth Zorn
University of Tennessee, Knoxville

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes
Part of the Home Economics Commons

Recommended Citation
Zorn, Nancy Elizabeth, "A Relationship Between Vitamin B12, Folate, Ascorbic Acid, and Mercury
Metabolism. " Master's Thesis, University of Tennessee, 1988.
https://trace.tennessee.edu/utk_gradthes/3864

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Nancy Elizabeth Zorn entitled "A Relationship
Between Vitamin B12, Folate, Ascorbic Acid, and Mercury Metabolism." I have examined the final
electronic copy of this thesis for form and content and recommend that it be accepted in partial
fulfillment of the requirements for the degree of Master of Science, with a major in Human
Ecology.
John T. Smith, Major Professor
We have read this thesis and recommend its acceptance:
Betsy Haughton, Michael H. Sims, Roy Beauchene
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a dissertation written by Nancy Elizabeth Zorn
entitled "A Relationship Between Vitamin B12, Folate, Ascorbic Acid,
and Mercury Metabolism." I have examined the final copy of this
dissertation for form and content and recommend that it be accepted in
partial fulfillment of the requirements for the degree of Doctor of
Philosophy, with a major in Human Ecology.

We have read this dissertation
and recommend its acceptance:

-........

-··
Accepted for the Council:

Vice Provost and
Dean of The Graduate School

A RELATIONSHIP BETWEEN VITAMIN 812 , FOLATE,
ASCORBIC ACID, AND MERCURY METABOLISM

A Dissertation
Presented for the
Doctor of Philosophy
Degree
The University of Tennessee, Knoxville

Nancy Elizabeth Zorn
August 1988

DEDICATION
To my earthly father, William C. Zorn, who passed away the week this
endeavor began but who lives daily in my memories. He instilled in me
the belief that I could attain any goal.
And to my Heavenly Father who gives me Eternal Life.
spiritual guidance to attain His goals for me.

He provides the

ACKNOWLEDGEMENTS
As is true is so many circumstances of life, there are many people
who have been helpful in achieving this degree.

The list is too lengthy

to mention everyone but a few individuals deserve special recognition.
I wish to thank Dr. John T. Smith who served as major professor
and mentor during this endeavor.

His patience and guidance has been

priceless in the last few years.
Deep appreciation is also extended to those members of my
committee.

Dr. Betsy Haughton provided much needed editorial advice and

gave insight for improving this project.

Statistical advice was

supplied by Dr. Roy Beauchene who also added humor to everyday events.
And finally, Dr. Michael Sims, who gave me an opportunity to learn new
research techniques and provided knowledge and resources in
neurophysiology.

His mental stimulation and availability was indeed

appreciated.
My graditude is acknowledged to Wendy Bubb for her assistance and
thoughtfulness.

Furthermore, I would like to thank the Department of

Nutrition and Food Sciences and Agricultural Experiment Station for
providing financial support for my graduate study.
Numerous friends and family members have been extremely important
to me during my lifetime and have influenced my pursuit of this degree.
Dr. Nancy Green has served as a role model and friend for many years.
I hope I can inspire others as she as inspired me.

My mother, Elizabeth

C. Zorn, has always provided love and strength even during the tough
times.

She taught me the true worth of education.

i ii

And lastly, much appreciation is extended to Karyn and Heather
Holbrook.

They tolerated the frustrations, gave encouragement during

the low times, and offered praise to make the efforts worthwhile.
support will be remembered in the many years to come.

iv

Their

ABSTRACT
The effect of megadoses of vitamin B12 , folate, and vitamin Con
the in vivo methylation of mercurfc chloride was studied in guinea pigs.
The incorporation of high levels of vitamin B12 , folate, and vitamin C
resulted in a decrease in both inorganic mercury and methylmercury
concentrations in all tissues except the lung and heart compared to
controls.

However, percent methylmercury levels tended to increase with

vitamin treatment.
The addition of megadoses of vitamin B12 fed either singularly or
in combination with the other vitamins resulted in increased
methylmercury concentrations in the liver, spleen, and kidney tissues of
the guinea pig.

Moreover, percent methylmercury levels increased with

B12 treatment in the liver, heart, and kidney.

Incorporation of high

levels of folate into the dietary regime also affected the mercury
methylation process particularly in the liver, heart, kidney and hair
tissues.

However, this effect was observed most often in animals fed

both B12 and folate.

Vitamin C appears to play a synergistic role with

vitamin B12 and/or folate in the methylation of mercury.
Auditory brainstem responses (ABR) produced results which
supported the theory that vitamin B12 treatment can potentiate the
mercury effect in the auditory pathways of the guinea pig.

Wave

latencies were longer and threshold values were higher in animals fed
megadoses of B12 •

Interpeak latency means were also longer in animals

treated with vitamins and mercury compared to untreated controls.

V

Rats fed diets supplemented with either methionine or cysteine
exhibited differences in methylmercury levels.

Both methionine and

cysteine supplementation resulted in a significant increase in percent
methylmercury levels in the liver and kidney.
These data indicate that megadoses of vitamin 812 , folate, and/or
vitamin C may alter the methylation process of mercury in vivo.

In

addition, methionine or cysteine supplementation can effect the
metabolism of mercuric chloride possibly via transmethylation processes.
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CHAPTER I
INTRODUCTION
Mercury has been recognized as a hazardous environmental pollutant
since the outbreak of mercury poisoning in Minamata Bay, Japan, in the
1950's.

People were poisoned as a result of consuming fish which had

acquired high concentrations of methylmercury due to contamination of
local waters with industrial waste (1,2).
in Iraq during 1971-72 (3).

Mass poisonings were reported

Grain which was treated with mercurial seed

dressings was issued to Iraq farmers in 1956 and 1960 for planting but
economic conditions resulted in its improper use as food (3,4).

Several

outbreaks of poisoning due to the use of treated seeds for food were
subsequently reported (2,4,5).
Despite these events, mercury is still widely used in the
production of certain chemicals, fungicides, insecticides, paints, and
electrical equipment (6,7).

In addition, many industrial waste products

contain mercury and are discarded in oceans, rivers, lakes, and
landfills (6,7). A more recent concern is the level of mercury exposure
as a result of dental amalgams.

Thus, the general public continues to

be exposed to mercury from a number of rather widespread sources. As a
result, many toxicological studies have been conducted to explain the
distribution, mode and site of action and elimination of mercury in
animals.
Mercury is toxic in either the metallic or divalent form; however,
the chemical form and dose alters the selection of the target organ (7).
It has long been known that mercury and its organic form, methylmercury,
1

are neurotoxic.

Although there have been a large number of neurological

studies conducted using animal models, only a few have explored the
visual and otological deficits caused by mercury.
Methylmercury has been shown to be highly toxic to mammalian
systems.

The biological formation of methylmercury requires the

coenzyme methyl-cobalamine (vitamin B12 } (8). Additionally, it is
logical to assume that the regeneration of methyl-cobalamine would
require one of the forms of tetrahydrofolate (folacin} (9).

Therefore,

it appears conceivable that individuals who consume megadoses of these
vitamins, B12 and folacin, would increase their potential to form
methylmercury.

It has also been shown that the addition of ascorbic

acid to an incubation mixture enhances methylmercury-induced lipid
peroxidation in the mitochondria (10).

Additionally, studies have shown

that ingestion of megadoses of vitamin C with other vitamins permits
increases in the level of metabolically active cobalamin (vitamin B12 }
as well as other vitamins (11).

The purpose of this investigation was

to examine if there is a relationship between consumption of
megavitamins and mercury retention and metabolism.
Research Hypothesis
Since this project consisted of three distinct investigations,
there were three separate research questions:
1)

Ho: The ingestion of megadoses of vitamin B12 , fol ate, or
ascorbic acid will not result in increased methylation and
retention of mercury as methylmercury in the liver, heart,

2

spleen, kidneys, brain, muscle, lungs, blood or hair of the
guinea pig.
Ha: The ingestion of megadoses of vitamin B12 , folate, or
ascorbic acid will result in increased methylation and
retention of mercury as methylmercury in the liver, heart,
spleen, kidneys, brain, muscle, lungs, blood or hair of the
guinea pig.
2)

Ho: A casein-based diet supplemented with methionine or
cysteine will not result in increased methylation and
retention of mercury as methylmercury in the liver, heart,
spleen, kidneys, brain or lungs of rats.
Ha:

A casein-based diet supplemented with methionine or

cysteine will result in increased methylation and retention
of mercury as methylmercury in the liver, heart, spleen,
kidneys, brain or lungs of rats.
3)

Ho:

A diet containing megadoses of vitamin B12 , folate, or

ascorbic acid will not effect mercury metabolism in guinea
pigs as demonstrated by altered auditory brainstem responses.
Ha:

A diet containing megadoses of vitamin B12 , folate, or

ascorbic acid will effect mercury metabolism in guinea pigs
as demonstrated by altered auditory brainstem responses.

3

CHAPTER II
REVIEW OF LITERATURE
Mercury Assessment Measurements
The best non-invasive indices of exposure to methylmercury are
levels of mercury in hair and blood {12).

Studies in Scandinavia on the

metabolism of trace amounts of radiolabeled methylmercury by humans have
shown that methylmercury is completely {more than 95%) absorbed from
food and is rapidly distributed throughout the body.

These studies also

allowed calculation of the half-life of mercury in humans {about 70
days) and provided information regarding the relative concentration of
mercury in the various parts of the body {12).

Additional studies have

shown the relationship between ingestion of methylmercury from
contaminated fish and mercury levels in the blood and hair {12).
Blood measurements are of great diagnostic and prognostic
significance because there is an equilibrium between tissue
concentrations and blood level {13).

However, the central nervous

system {CNS) stands out as an exception to this.

Both the brain and

cerebellum may still contain significant amounts of methylmercury
even several years following exposure and while the kidneys, liver, and
blood have returned to normal values.

Therefore, the CNS appears to

accumulate methylmercury over much longer time spans than any other
organ and consequently, the degree of concentration in the CNS is not
reflected reliably by blood measurements {13).

4

Due to several unique properties, hair has gained a more important
role in the assessment of both mercury exposure and body burden.

First,

hair contains a number of sulfhydryl groups which act as binding sites
for mercury ions and radicals (13).

As a general rule, the mercury

concentration in hair is 250-300 times higher than that in blood.
Therefore, the higher concentrations yield more reliable measurements
(14).

Secondly, since hair growth resembles ary extrusion process with a

mean growth rate of 1 cm/month, analysis of segments (1 cm long) of hair
can provide mean monthly blood concentrations of mercury throughout one
year prior to sampling (13,14).
Urine sampling has also been used as a method of determining
inorganic mercury exposure.

However, the mercury content of urine

displays such wide individual variation, depending on fluid intake, type
of food and many other factors, that it is impossible to derive any
meaningful definition of normal values and any definite conclusions
about the body burden (13).

While the mercury content of urine yields

little information about the body burden, it has occasionally been used
as a diagnostic tool.

For example, following a sudden and known

ingestion of mercury salts, the urinary content serves as an indicator
of uptake.

Alternatively, when a patient is given treatment for removal

of a high body burden of mercury, the urinary content will reflect
tissue release of incorporated mercury and thus, the effectiveness of
the therapy (13).

5

Health Risks
In 1984, the United States Environmental Protection Agency (15)
estimated that the average daily retention of mercury for the adult
population was 153 nanograms per day for atmospheric Hg which is the
predominant form of elemental mercury vapor.

This is for the general

population or one which is not occupationally exposed to the element.
Retention of organomercurials mainly as methylmercury from fish was
estimated at 3666 nanograms per day.

Consumption of inorganic mercury

compounds derived from nonfish dietary products was predicted to be 2000
nanograms per day with 5 nanograms per day consumed in drinking water
(15).
However, it was suggested that these estimations should be
considered highly provisional since their derivation was predicated on
an approach totally at variance with the "real world" situation in which
human beings are exposed simultaneously to many interacting
environmental chemicals.

In addition, these estimates are seriously

influenced by such factors as degree of environmental pollution peculiar
to each geographic zone, ambient temperature, humidity, sex, race,
dietary habits, prevalence of disease and conditions of stress (15).
Another important source of the human burden of mercury which was
not considered in these estimations is the widespread daily use in some
black communities, both in developed and third world countries, of
depigmentation soaps and other cosmetic products which contain 3-5%
mercuric salts.

These mercuric salts, which are applied to the skin as

ointments in suitable lipid vehicles, are readily absorbed and retained
in the body (16).
6

In recent years, a number of articles (17,18,19) have indicated
that fish consumption is beneficial in prevention of cardiovascular
disease.

However, studies have also shown that fish contaminated by

mercury spills, particularly methylmercury, can present a potential
human health hazard.
A recent study was conducted by the Food and Drug Administration
(FDA) (12) to evaluate fish consumption in the United States and
calculate possible exposure to methylmercury.

A consumption study which

was commissioned by the Tuna Research Foundation in 1973-74 was used to
determine the intake of fish and shellfish in the U.S.

The average

consumption of total seafood per individual was 18.58 ounces per month
or approximately 18 g/day with 61.5% of the individuals sampled eating
tuna.

Mercury residue levels in domestic fish sampled by the FDA were

then used to calculate the level of exposure to methylmercury.
According to OSHA, the maximum permissible exposure limit for mercury is
0.1 mg/m3 and the threshold value for organic compounds is 0.001 ppm
(20).

At this level, the U.S. fish consumption data did not indicate

any cause for concern of methylmercury poisoning for the average
American (12).
However, studies conducted in other countries have shown slightly
different results.

A human metabolic study done in Japan examined the

intake of tuna in relation to mercury concentrations in human hair (21).
It was clearly shown that an increase in the mercury concentration in
the hair was approximately proportional to the amount of tuna flakes
consumed.

It was, thus, suggested that those populations consuming

large quantities of fish should be monitored in order to prevent mercury
7

poisoning (21).

However, a recent study (22) examining methylmercury

exposure and mortality in Japan found that there was no appreciable
difference in life expectancy in populations of methylmercury-exposed
areas as compared to control areas.

However, the authors suggested that

further investigation was needed to provide more insight into the
delayed effect of methylmercury exposure on human health (22).
A study done by Mason in 1987 surveyed the mercury content of eel
and roach taken from 67 sites in Great Britain (23).

On the average,

eels contained significantly more mercury than roach.

It was also

determined that concentrations of metals in eels may more closely
reflect environmental levels and could possibly be used as an indicator
species.

Twenty-five percent of the eels sampled exceeded recommended

standards for human consumption.

While freshwater fish do not figure

much into.the diet of most Britons, there is a growing export of eels to
mainland Europe and, therefore, it may be advisable to initiate a
program of monitoring freshwater fish for heavy metals (23).
Dermelj et al. (24) measured the levels of mercury, methylmercury,
and selenium in scalp hair of populations from Mediterranean areas.
Populations which consumed minimal amounts of seafood had very low
concentrations of total mercury and methylmercury and a high ratio of
mercury to methylmercury.

However, populations from Yugoslav and the

Greek coastal areas had elevated mercury levels in scalp hair with most
of the mercury as methylmercury.

This population had a high consumption

of fish, shellfish, and other edible sea products.

This study indicated

that the elevated concentration levels of mercury in the scalp hair of
these populations can be "directly attributed to the higher consumption"
8

of seafood products (24).

This concept has been supported by research

done in New Guinea (25), the United Kingdom (26), and Spain (27).
Another concern that has been investigated recently is the level of
mercury exposure which may result from dental amalgams, particularly
among dental professionals.

Silver-amalgam is still the cheapest, most

durable, and most extensively used restorative material in dentistry for
repair of decayed posterior teeth.
this alloy by weight (16).

Mercury accounts for about 50% of

Sources of mercury exposure which exist in a

dental office include accidental spills, poor mercury hygiene, manual
mulling to express excess mercury from freshly mixed amalgam, mechanical
amalgamators, ultrasonic amalgam condensors, failure to use high-vacuum
suction while removing old amalgam restorations and improper dry heat
sterilization of amalgam-contaminated instruments (28).
A recent comprehensive assessment of the magnitude of mercury
exposure in 4,272 US dentists focused on urinary levels of mercury (28).
Urinary mercury levels ranged from 0-556 µg/liter with a mean level of
14.2 µg/liter.

It was noted that urinary mercury levels were related to

geographic location within the country, dental specialty, type of
air-conditioning in the practice, duration of working hours, and,
especially, number of amalgam restorations placed or removed weekly,
years in a dental specialty, and years in the current office facility.
For example, a four-fold increase in urinary mercury level was observed
in general practioners compared to orthodonists, and more than 31% of
the dentists with urinary mercury levels in excess of 50 µg/liter
practiced more than 40 hours per week (28).

These results were

supported by a more recent study which showed a significantly higher
9

blood level of mercury in 205 practicing dentists compared to non-dental
controls (29).
One study also indicated that subjects with dental amalgams had
unstimulated mercury vapor concentrations significantly higher than
basal levels of control subjects with no amalgams (30). With chewing,
these levels increased six-fold over unstimulated mercury levels, or a
54-fold increase over levels observed in control subjects (31).
Therefore, it has been concluded that dental amalgam mercury makes a
major contribution to total daily dose levels.
Site of Toxicity
Studies have shown that inorganic mercury and methylmercury are
distributed in the body at different sites.
treated rats of both

Mitsumori et al. (32)

sexes with various levels of methylmercury

chloride and determined that the hair had high levels of mercury,
while subsequently lower levels were found in the kidney, blood, liver,
and nervous tissues, respectively (32).

Blood biochemical examinations

revealed that cholesterol and urea nitrogen increased which may have
indicated toxic renal damage.

These researchers found sex differences

in clinical signs, mortality, body weight, hematology and blood
biochemistry within the treated groups (32).
Thomas et al. (33) determined that the distribution of mercury is
affected by the sex of the animal.

Female Long-Evans rats were able to

excrete organic mercury more rapidly than their male counterparts.

In

fact, whole body clearance of mercury was faster in females than in
males.

It was determined that female rats had significantly higher mean
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percentages of the methylmercury dose located in the kidney and brain,
while males had higher mean percentages of the dose in pelt and whole
body (as organic or total mercury).

A sexual difference was also shown

in accumulation or retention of inorganic mercury in the nervous system.
The reported sexual differences in methylmercury toxicity may be
explained by these sexual differences in distribution and retention of
organic and inorganic mercury following methylmercury exposure (33).
Alexander and Aaseth (34) found that the organ distribution of
mercury was altered with administration of cysteine or glutathione.

A

rapid uptake of mercury in the kidney and a depressed content in the
liver and blood was observed in female rats given an intravenous
injection of methylmercury chloride premixed with glutathione or
cysteine as compared to animals given methylmercury alone.

Following

exposure to methylmercury, the physiological formation of a
methylmercury-glutathione complex takes place mainly intracellularly.
Since the liver has the ability to synthesize glutathione, it is a
primary site for the conjugation of methylmercury and glutathione.
Additionally, the liver cells are able to export large amounts of this
complex into the bile which reduces the liver content of methylmercury.
The addition of cysteine increases the amount of methylmercury binding
since it probably increases the intracellular levels of glutathione.

It

was noted that this complex can be reabsorbed from the gut and is
rapidly extracted from the blood plasma by the kidneys (34).
A recent study by Atchison et al. (35) examined the effect of
methylmercury at the nerve terminals.

It has been shown previously that

methylmercury blocks nerve-evoked release of acetylcholine, while
11

spontaneous quantal release of acetylcholine is first increased then
decreased (35,36).

These changes in spontaneous quantal release of

transmitter are measured electrophysiologically as alterations of
miniature endplate potential (MEPP) frequency (36).

This is not due to

impaired postjunctional sensitivity (37) or exhaustion of releasable
transmitter stores (38).

The present study investigated the idea that

methylmercury might suppress nerve-evoked transmitter release by
blocking the nerve terminal calcium channels which open during
depolarization and permit calcium to enter which then triggers the
release of transmitter.

It was shown that methylmercury blocked the

depolarization-induced calcium influx irreversibly and noncompetitively
at the nerve terminals in both the central and peripheral nervous
system.

The block of calcium uptake by methylmercury was shown to

differ from that of mercury in two ways.

First, methylmercury reduces

the total influx of calcium through a voltage-dependent pathway less
effectively than inorganic mercury.

Second, inorganic mercury more

potently and efficaciously blocks the slow phase of calcium uptake,
while methylmercury appears to block the fast phase of calcium uptake
more effectively.

However, the efficacy of methylmercury as a blocker

is greater for the slow than fast components (35).
This study was later supported by Levesque and Atchison in 1987
(36) in which it was shown that methylmercury-induced stimulation of
quantal release of acetylcholine at the neuromusclular junction was not
blocked by agents which depolarize the mitochondrial membrane.

However,

the quantal release was blocked by an agent which blocks calcium influx
specifically via the so-called "uniporter".
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Therefore, simple

inhibition of mitochondrial function does not prevent methylmercury from
causing an increase in minature end-plate potential (MEPP) activity.

It

was suggested that methylmercury may interact with the mitochondria to
induce the release of bound calcium stores into the nerve terminal
cytoplasm.

This increase in free ionized cytosolic calcium in turn is

thought to promote the increased quantal discharge of acetylcholine
observed as increased frequency of MEPP's (36).
Neurotoxicity
Although it has been well established that mercury and its
derivatives are severe neurotoxins (1,3), the exact molecular basis of
organic mercurial-induced neurotoxicity in humans and animals is largely
unknown.

Methylmercury, in contrast to the inorganic forms, passes with

ease through physiologic barriers, such as the blood-brain barrier,
blood-testes barrier, and placenta (39).

Neuropathologic observations

reveal the cortex of the cerebrum and cerebellum are selectively
involved with focal necrosis of neurons, their lysis, and phagocytosis,
and replacement with increased numbers of supporting glial cells.

These

changes are most prominent in the deeper fissures such as the visual
cortex and insula (39).
Omato et al. (40) demonstrated an inhibition of amino acid
incorporation associated with possible defects in the cytosol fraction
and microsomes isolated from brains of mercury-treated animals.
However, they concluded that the primary site of organic mercurial
action is not the protein synthetic per se.

It was suggested that the

ne·urotoxicity of mercury may be associated with other intracellular
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processes coupled with the formation and/or regulation of the protein
synthetic apparatus (40).
Cheung and Verity (41) compared the perturbation of brain protein
synthesis by methylmercury chloride in vivo and in vitro.

These

researchers found that stimulation of amino acid incorporation following
in vivo administration of methylmercury was apparently associated with
the ribosome fraction, while in vitro preincubation of the
postmitochondrial supernatant with methylmercury produced stimulation
associated with the pH 5 enzyme fraction.

A model was proposed to

explain the effects of methylmercury on brain protein synthesis which
involves the existence of an inhibitor (or regulator) of protein
synthesis that is highly sensitive to methylmercury.

A more recent

study by Cheung and Verity (42) identified the locus of mercurial
inhibition of translation as a perturbation in the aminoacylation of
tRNA which is not associated with defective initiation, elongation, or
ribosomal function (42).
The distribution and concentration of mercury in various areas of
the brain have been studied by several investigators (43,44), but
comparatively few microanatomical studies have been directed towards
revealing the pathogenesis of the neurological lesions in mercury
intoxication.

Moller-Madsen and Danscher (45) examined the localization

of inorganic mercury in the central nervous system of the rat.

Adult

Wistar rats of both sexes were given mercuric chloride in the drinking
water at a dose level of 20 mg HgCl 2/liter distilled water ad libitum
during an 8-month period.

The animals were subsequently sacrificed and

coronal sections of the brain and cervical spinal cord were examined
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according to a histochemical technique based on a physical development
process that makes mercury deposits visible {45).
It was found that mercury deposits were not uniformly distributed in
the brain and most mercury was located in the rhombenephalon.

There was

a clear tendency for those regions in the brain stem and cerebellum
which are primarily associated with motor systems to contain the
heaviest mercury accumulation.

In fact, significantly more mercury was

found within the motor nuclei than in sensory nuclei.

Microscopic

examination showed that within the regions of mercury deposition, large
cells generally contained more mercury than smaller cells and that
mercury was located intracellularly with neurons containing more mercury
than glial cells {45).
Research with methylmercury has provided a slightly different
distribution pattern {46,47).

Vandewater and associates {48)

investigated the distribution, metabolism, and neurotoxicity of
methylmercury using Swiss albino mice.

An oral dose of [203 Hg]

methylmercury chloride {lOmg/kg) was given to male mice for a period of
1 to 9 days.

The methylmercury was evenly distributed among the

posterior cerbral cortex, subcortex, brain stem, and cerebellum.

The

anterior cerebral cortex had a significantly higher methylmercury
concentration than the rest of the brain.· A general trend of decreasing
structural damage was observed with the cerebral cortex greater than the
cerebellum greater than the subcortex greater than the brain stem.

This

uneven pattern of structural damage did not correlate with the brain
distribution of methylmercury.

It was suggested that various areas of

the brain differ in their sensitivity to methylmercury since all areas
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have the same methylmercury concentration and yet display different
degrees of structural damage (48).
Obviously, inorganic mercury and methylmercury are distributed
differently in the brain and, at present, there is no satisfactory
explanation for these differences.

It has been suggested that inorganic

mercury disrupts the barrier function of the plasma membrane first and
then moves into the cell, inhibiting cellular functions.

Methylmercury,

on the other hand, penetrates the cells without any noticeable damage to
the barrier.

Therefore, the observed differences in the handling of

mercuric chloride could be explained due to the differences between the
plasma membranes of the motor and sensory neurons (48).
Behavioral and neurophysiological changes are the earliest, and
sometimes the only, indicators of chronic effects of exposure to
neurotoxic agents (49,50).

Clinical studies on patients exposed to

mercury have shown a disturbance of visual perception as one of the most
consistent signs of neurological impairment in humans.

A concentric

narrowing of the visual fields and reduced visual acuity is typically
exhibited.

The neurologic impairment underlying these visual anomalies

appears to be lesions of the primary visual cortex.
O'Kusky (51) examined the ultrastructural changes in neurons and
synapses of the primary visual cortex in rats exposed to methylmercury
in order to identify the morphologically distinct cell types undergoing
degeneration at the onset of neurologic impairment.

Subcutaneous

injections of methylmercuric chloride in physiological saline were given
to neonatal rats at a dose of 5 mg Hg/kg/day beginning on postnatal day
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5.

The injections were continued until the animal demonstrated a

persistent weight loss for 48 hours (51).
Clinical signs of neurologic impairment were relatively consistent
among the nine methylmercury- treated animals with all animals
exhibiting some degree of visual impairment.

The vibrissa-placing and

forelimb-placing responses appeared normal, but the visual-placing
response was weak or absent.

The methylmercury-treated animals, unlike

the controls, failed to avoid a visual cliff, and when placed in a novel
environment demonstrated difficulty in negotiating obstacles (51).
In four of the methylmercury-treated animals convulsive activity
was displayed and lesions of the primary visual cortex were more
extensive than in the nonconvulsive animals.

Examination by electron

microscopy of the visual cortex in the nonconvulsive animals showed a
selective degeneration of axon terminals forming symmetric synapses.

It

was suggested that a specific class of cortical neuron, the aspinous or
sparsely-spinous ~tellate neuron, is particularly vulnerable to
methylmercury toxicity.

These neurons have been shown to form symmetric

synapses in the visual cortex of the rat and contain glutamic acid
decarboxylase which is the enzyme that synthesizes the neurotransmitter,
Y-aminobutyric acid (GABA).

The GABAergic inhibition of the neocortex

is mediated by these intracortical neurons (51).
The relatively selective impairment of GABAergic neurons in the
visual cortex that occurs with methylmercury poisoning is consistent
with the visual abnormalities that have been reported.

For example,

with impairment of the GABAergic neurons, a loss of orientation
specificity in neurons of the visual cortex would explain the decreased
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visual acuity.

In addition, a loss of directional specificity may

contribute to the concentric narrowing of the visual field as reported
in some cases of methylmercury poisoning.

The convulsive behavior

exhibited by some of the animals exposed to methylmercury was suggested
to reflect a seizure-induced pathology secondary to methylmercury
impairment of GABAergic interneurons of the cerebral cortex.

The exact

cellular mechanism underlying the preferential degeneration of stellate
neurons and symmetric synapses in methylmercury-treated animals is
unclear.

However, it has been proposed that an inhibition of

mitochondrial respiration is involved (51).
Slotkin and Bartolome (52) also examined alterations in nerve
signal transmission with methylmercury toxicity.

It was shown that

postnatal exposure to methylmercury resulted in changes in
neurotransmitter uptake and turnover in presynaptic terminals, as well
as development of postsynaptic adrenergic receptor binding sites.

These

alterations resulted in aberrant signal transmission across the synapse.
Therefore, the neurotoxicity observed with methylmercury may be due to
degeneration of nerve synapses (52).
Several recent studies conducted by Aschner in 1986 {53,54)
examined changes in axonal transport in the rat optic system with
methylmercury exposure.

In one study, alterations in

axonally-transported proteins in the retinal ganglion cells of rats were
examined following exposure to methylmercury.

Several groups

of rats were given injections of methylmercury (4 mgHg/kg/day) for
durations of 4-6 days and 12 days.

Scintillation, histological, and SOS
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polyacrylamide electrophoresis studies were employed to determine axonal
transport (53).
An increased rate and volume of transported protein-bound
radioactivity was observed in the visual system of the mature rat
treated with methylmercury.

This is consistent with reports that

synthesis and axonal transport increase when degenerative changes in the
nerve create a demand for repair substances.

Therefore, the increase in

rate and volume of flow in the methylmercury-treated visual system of
rats presumably reflects metabolic alterations designed to increase the
supply of materials to the nerve terminal.

It may represent a period of

compensation during the early stages of methylmercury exposure (53).
The composition of the transported polypeptides was analyzed by gel
electrophoresis and selective changes were evident.

These changes

occurred in a small subset of proteins known as GAPs (growth-associated
proteins).

This indicated that the rat's visual system has the capacity

to attempt regeneration; however, it is not clear whether this process
can be maintained for long periods of time (53).
It is well known that a latency period occurs between the time of
administration of methylmercury and the onset of symptoms.

It has not

been determined whether increased protein synthesis and axonal transport
are maintained throughout the symptomatic stage of methylmercury
exposure.

It needs to be determined if exhaustion of protein synthesis

and axonal transport is correlated to the onset of functional deficits
in these animals (53).
Aschner's study helps explain the great specificity of
methylmercury-induced injury in certain animal models, since some
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systems appear to have regenerative capabilities (e.g. visual) .while
other systems appear to fail in this aspect (e.g.-sciatic). It is
important to understand these regenerative processes if future studies
are to examine the effects of methylmercury on the visual system (53).
Additional research has examined the effect of methylmercury on
visual-evoked potentials (55) and spatial vision (56).

It was shown

that methylmercury decreased latencies of visual-evoked potentials and
impaired spatial vision.

Therefore, it would appear that methylmercury

treatment has various effects on the visual system (55,56).
One of the side effects of methylmercury poisoning is sensorineural
hearing loss with subsequent impairment of speech discrimination.
Morphological studies have shown damage to the cochlea and outer hair
cells in the apex of the cochlea as well as the sensory epithelium and
peripheral myelinated nerve fibres in the crista ampullaris with chronic
inorganic mercury intoxication (57,58) .. However, the hearing loss due
to methylmercury cannot be explained solely on the basis of receptor
cell lesions (57).
Wu and coworkers (57) examined cutaneous and
rats following methylmercury poisoning.

auditory function in

Rats were given various doses

of methylmercury chloride subcutaneously over a course of 5 days. Then,
at varying times after the toxic exposure, up to one year, their sensory
functioning was assessed using the behavioral method of reflex
modification (57).
The first signs of cutaneous deficits and hearing impairments were
noted about 1 to 2 weeks after exposure to the higher dosages of
methylmercury (40 and 50 mg/kg).

These effects were revealed by
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decrements in startle inhibition produced by both transient auditory
stimuli and also by shocks to the tail which preceded the acoustic
startle reflex {57).
These deficits in cutaneous sensitivity and changes in reactivity
are consistent with neurological damage produced in the periphery of the
nervous system by exposure to methylmercury.
are more difficult to explain.

However, auditory deficits

In the auditory processes of the

superior temporal gyrus, central lesions have been observed in the
primate brain.

It has been suggested that these lesions may be at least

partially responsible for the impairments in auditory perception noted
in exposed humans.

Since these impairments have been observed to be

temporary in the rat, it was hypothesized that methylmercury produces
demyelination in the auditory nerve which is equivalent to that seen in
the dorsal roots of the spinal cord.

Damage to the large fibers in the

auditory nerve would thus impair the detection of rapid transients and
other high frequency stimuli which is normally observed in humans
exposed to methylmercury.

However, some recovery may be seen following

neural repair {57).
Only a limited number of clinical methods exist for evaluating
sensory, perceptual, and even motor systems in animals.

However, it is

known that the brain produces consistent and time-locked changes in
electrical activity in response to auditory stimuli.

Surface electrodes

can be used to record these evoked potentials from auditory structures
in the brainstem.

These responses are referred to as auditory brainstem

evoked responses {ABER) or auditory brainstem responses {ABR).

Evoked

response testing is a non-invasive technique which provides highly
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objective information without subject cooperation.

Thus, ABR

evaluations are used by many investigators to detect neurologic,
otologic or audiologic dysfunction in both human beings and animals
(59,60).

Auditory brainstem responses are averaged recordings of brain
activity which result from an externally applied acoustic signal.

By

averaging these recordings, the background electrical activity can be
extracted from the low voltage evoked components.

The recordings

consist of numerous waves with positive and negative peaks.

Each wave

represents composite neuronal activity of 1 or more brain structures.
The activity of neural generators at progressively higher levels in the
neuroaxis are generally represented by waves of successive auditory
evoked responses with the early latency components arising almost
totally within the brainstem.

Thus, auditory brainstem responses

reflect electrical events in the VIIIth cranial nerve and within the
brainstem components of the auditory pathway (59).
A number of studies have been conducted in an attempt to describe,
from an anatomic perspective, the neural generators of the ABR waves.
However, it has not been possible to identify a given wave with a single
nucleus or tract due to the complexity of the sound pathway and perhaps
the variability among animal species.

Even so, a proposed scheme has

been derived from a variety of experimental studies to relate each ABR
wave as a reflection of a generator system.

There is general agreement

that Wave I of the ABR is produced by acoustic nerve activity.

Wave II

appears to be generated from the cochlear nucleus, however, there is
less agreement concerning the origin of this wave.
22

Research suggests

that the generator of wave III is the trapezoid body and/or superior
olivary complex but attempts to differentiate discrete nuclei of the
complex have been unsuccessful.

Waves IV and V appear to originate from

the area around and within the inferior colliculus.
species, waves

In certain animal

VI and VII will be exhibited in ABR measurements but the

generators for these waves remain unclear (59,60).
Latency measurements of wave I can be used to examine the time from
the inner ear or cochlea to the cochlear nerve.

Therefore, this

information may be used to indicate peripheral nerve damage which would
effect the signal transmission to the CNS.

Auditory threshold data can

also be used to indicate this type of alteration.

Wave amplitude data

may be used to indicate the strength of the stimulus as the action
potential reaches the different auditory centers of the brainstem.
Interpeak latency (IPL) for waves I and Vis defined as central
transmission time, and appears to be a good indication of impulse
transmission through the brainstem, at least to the level of the
inferior colliculus which is assumed to be the generator of wave V.
Lesions involving the cochlear nerve and brainstem have been shown to
result in a prolonged IPL.
Thus, auditory brainstem response testing can be used to assess
neurologic diseases, hearing impairment, as a measure of CNS maturation,
and in monitoring the treatment of CNS disease.

These diagnostic

procedures have also been used in veterinary medicine to examine the
effect of mercury intoxication on the auditory system of animals.
A study was done by Wassick and Yonovitz (61) in which
methylmercury ototoxicity was determined using auditory brainstem
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responses.

Two groups of mice were given subcutaneous injections of

either 4 mg/kg for 17 consecutive days or 8 mg methylmercury/kg for 6
days. Auditory brainstem responses were obtained as a result of
pure-tone stimulation (4 to 78 kHz).

To assure normal audibility and

provide a baseline measure, pretreatment responses were obtained from
each animal.

Recordings were then taken weekly for three weeks after

the initial injection.

Latencies and physiologic thresholds were

obtained from all 18 mice to assess methylmercury toxicity in order to
elucidate which areas of the lower auditory pathway were affected (61).
The 4 mg/kg group showed significant threshold deficits at all dose
test periods.

The decrement persisted up to the last test period which

suggested that the deficits were permanent.

The frequency having the

greatest deficit was at 32 kHz, confirming a high-frequency loss (61).
Significant threshold decrements with similar patterns to the lower
dose group were also found in the 8 mg/kg group.

However, the 16 kHz

was the most affected frequency suggesting a loss in the most
audibility range for mice.
great in this group.

sensitive

In addition, the overall deficit was not as

The reasons for these differences between dose

groups were obscure, but may be related to differences between effects
caused by acute and subchronic levels of methylmercury in the auditory
system.

Electron microscopic examination of the vestibular hair cells

has shown a greater hair cell loss in chronically dosed animals than in
the acute case and this is supporting evidence for a dose-dependent
effect on the auditory pathway (61).
Striking differences from pretreatment values were revealed in
analysis of the latency test parameter.
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Loss in the high-frequency

range was suggested to be due to frequency-specific deficits to the
lower auditory pathway.

Absolute latencies also tended to be shortened

for the majority of frequencies and time periods with methylmercury
exposure.

Thus, these authors proposed that this evidence indicated

that methylmercury affected nerve processes which regulated nerve
conduction velocity in the CNS.

They suggested the possibility that

methylmercury causes impairment of slow conduction.

Damage of the small

diameter fibers has been offered as one explanation for this
hypersensitivity in nerve tissue.

This would result in the majority of

transmission being derived from fast conducting, large diameter fibers.
If the small diameter fibers are more sensitive to methylmercury, this
makes the small diameter nerve fibers in the brainstem a possible target
for methylmercury (61).

However, this is contradictory to the mechanism

proposed by Wu et al. (57); therefore, further research is necessary to
determine if it is the large or small diameter nerve fibers which are
affected by methylmercury.
In summary, there appears to be a difference in distribution
patterns in the brain with exposure to inorganic mercury as compared to
methylmercury (43,44,45,46,47,48).

Various areas of the brain tend to

be more susceptible to neurological damage depending of the type of
mercury exposure (48).

Synaptic degeneration has been shown in the rat

visual cortex after administration of methylmercury.

Also,

methylmercury appears to preferentially attack certain neurons of the
visual system (51,52).

Changes in protein synthesis and axonal

transport in the visual system have been determined, thus promoting the
concept of regenerative processes occurring in the rat (53,54).
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Research done using ABR methods to investigate the effect of
methylmercury on auditory function has shown that this metal causes
high-frequency auditory deficits in mice {61).

Methylmercury may also

alter the conduction velocity of auditory nerve fibers and, therefore,
cause hypersensitivity in the brainstem, but it is unclear which fibers
are most affected {61).

In addition, methylmercury does appear to have

a differential effect on cochlear and the lower auditory pathway
depending on the dosage {61).

It is clear that future research is

needed to elucidate the mechanism of action by which methylmercury
affects the auditory systems.
Methvlation Process
Although poisoning by inorganic mercurials has

been known since

ancient times, only recently has there been greater attention to the
organic mercury compounds.

Approximately 80% of our daily intake of

mercury is methylmercury, with the average intake varying from 20 to 80
µg/day or more in heavily contaminated foods {39).

Methylmercury

compounds pass easily through the blood-brain barrier and the placenta
and are more likely to target the nervous system, testes, and the
developing embryo/fetus (12,39).

Additionally, the toxicity of

short-chain alkylmercury compounds, such as methylmercury, is
accentuated due to their persistence in mammals.
A number of mechanisms have been proposed for metabolism of
inorganic mercury in vivo.

Early research has shown that rats injected

with mercuric salts will excrete a small portion as volatile mercury,
thus, suggesting that these animals are able to convert inorganic
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mercury either by a methylation reaction or reduction to the metallic
form (62).

Additional research done by Ogata and associates (63,64) has

demonstrated that elemental mercury can be oxidized to produce the
mercurous ion, Hg 2 + 2 , and the mercuric ion, Hg++.

The mercuric ion can

then be reduced to metallic mercury due to the activity of the xanthine
oxidase system.

This can be reversed with catalase activity (64).

Another metabolic fate of inorganic mercury compounds is the
biomethylation of mercuric ions via methyl 812 which has been shown to
occur in certain bacteria (65,66,67).
Methylmercury is broken down slowly to inorganic mercury in the
mammalian organism, but the site of demethylation has been difficult to
determine (68).

Suda and Takahashi (66) recently suggested that the

spleen is an important site for the formation of inorganic mercury, and
that macrophages participate in this biotransformation.

It has been

shown that the gut microflora also participate in the splitting of the
carbon-mercury bond of methylmercury to produce inorganic mercury
(66,67).
Therefore, it is important to examine the process by which
inorganic mercury is converted to the potentially more toxic form of
methylmercury.

It has been established that bacteria not only in the

soil and lakes, but also the intestinal tract can convert metallic and
inorganic mercury forms to methylmercury (39,69,70,71,72).

Pan-Hou and

Imura (73) have shown that methylation of mercury which is mediated by
methycobalamin may play an important role in the detoxication of the
mercury by certain vitamin B12 -requiring strains of microorganisms.
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On the basis of oxidation-reduction chemistry, the conditions for
biomethylation can be formulated.

Methylating agents which are

available for methyl transfer in biological systems are known to involve
three major coenzymes: 1) S-adenosylmethionine; 2) N5 -methyltetrahydrofolate derivatives; and 3) vitamin 812 derivatives.

Research

has indicated that vitamin 812 derivatives are the methylating agents
for inorganic mercury salts since they are capable of transferring
carbanion methyl groups (CH 3-).

S-adenosylmethionine can donate

carbonium methyl groups (CH 3 +), while N5 -methyltetrahydrofolate can
yield free radical methyl groups (CH 3 .).

Since vitamin 812 is capable of

transferring methyl groups as free radicals (CH 3 .), carbonium ions, or
carbanions (Figure 1), theoretically there are three mechanisms which
may be involved in the methylation of a number of metals, such as gold,
tin, and platinum (8).
To date, two general mechanisms have been found for the methylation
of a metal or metalloid by methylcobalamin:

reactions in which the

metal or metalloid acts as an electrophile (type I) and reactions in
which the metal or metalloid acts to abstract a methyl radical (type
II).

The methylation of mercury is an example of type I which involves

heterolytic cleavage of- the Co-C bond of methylcobalamin with the
transfer of a carbanion methyl group to the more oxidized state of the
element, i.e. a carbanion methyl group is transferred to mercury to form
methylmercury and a water molecule coordinates in the fifth ligand site
of the cobalamin to give aquocobalamin [Co(III)] as a final product
(Figure 2) (8).
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An example of a type II reaction is the methylation of thiols by
methylcobalamin and involves reductive hololytic cleavage of the Co-C
bond of methylcobalamin with the transfer of CH 3 • and the production of
Co(II) cobalamin.

The CH 3 • couples with the attacking metal or

metalloid which results in a one-electron oxidation of the attacking
element (8).
There is a metabolic interrelationship between

folate, B12 , and

methionine, but several important points remain unclear (9,74).

The

reaction which involves the enzyme, N5 -methyltetrahydrofolate
methyltransferase, is an example of this interrelationship.

As shown in

Figure 3, this enzyme transfers a free radical methyl group from
N5 -methyl tetrahydrofolate to vitamin B12 (Co+2).

The B12 can then

donate the free radical methyl group to homocysteine to form methionine
and regenerate the Co+2 form of B12 •

Methionine can be used to form

S-adenosyl-methionine with the hydrolysis of ATP.

Occasionally, for

reasons not fully understood, the Co+2 form of B12 becomes oxidized to
Co+3.

When this occurs, riboflavin (FADH 2 ) can be used to reduce the

B12 to the Co+l form.

S-adenosylmethionine will donate a carbonium

(CH 3 +) methyl group to regenerate the Co+2 form of B12 •

Thus, the cycle

can begin again.
Use of Meqavitamins
Since vitamin B12 , and possibly folate, appear to be involved in
the methylation process of inorganic mercury, it is possible that
individuals consuming megadoses of these vitamins may exhibit elevated
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SAM

levels of methylmercury.

Thus, it becomes important to examine the use

of megavitamins in our society.
Vitamin advocates have in recent years argued that supplements,
often in amounts ten or more times higher than recommended, will guard
against a profusion of physical and psychological ills.

Consumption is

often encouraged by the philosphy that if a little is good, a lot is
better (75).

Consequently, the

supplement business has blossomed intoa

multibillion dollar industry due to the large-scale consumption of these
products.

It has been estimated that 40% to 50% of the adult

population, both active and sedentary, rely on self-prescribed vitamin
supplements (75,76,77). Athletes, coaches, and athletic trainers appear
to be choice targets for the supplement sales force (76).

Nutrition

articles and advertisements in popular sports magazines have convinced
some naive consumers that large doses of nutritional supplements are
required for the active individual (76).
The vitamin B complex is one popular supplement that athletes
consume.

It has long been assumed that the water-soluble vitamins are

nontoxic since excesses are excreted in the urine (76,78).

These 8

vitamins, thiamin, riboflavin, niacin, pyridoxine, folacin, panthothenic
acid, biotin and 812 , have been promoted to enhance athletic
performance, but research has not supported.this claim (76).
Additionally, megadoses of the B vitamins have been reported to cause a
number of side effects (78).
Probably the two most popular vitamin supplements are vitamin C and
E (76,78,79).

The sale of ascorbic acid supplements has skyrocketed due

to Linus Pauling's claim that massive doses of vitamin C can cure colds.
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Although the RDA for ascorbic acid is 60 mg a day, megadose advocates
say we need as much as 10,000 mg (79).

Like the B complex, vitamin C is

soluble in water and excesses are excreted.

No studies support the

efficacy of vitamin C supplements as an ergogenic aid, and undesirable
side effects have been demonstrated with large doses (76,80,81).
Potential Relationship of Megavitamins and Mercury Metabolism
Thus, as the research indicates, mercury presents human health
hazards due to contaminated fishing waters and dental amalgams.

Mercury

apparently can exhibit toxic effects at various sites throughout the
mammalian system and of significant importance is the possible
neurotoxicological effects as a result of methylation processes which
occur in vivo.

This biomethylation of inorganic mercury via vitamin B12

suggests that higher levels of this vitamin may increase the amount of
methylmercury found in the body.

With the increased consumption of

vitamin supplements in the United States, it is conceivable that mercury
toxicity could rise significantly.

Therefore, this project investigated

the effect of megadoses of vitamins on the metabolism of mercury in
various mammalian tissues.

In order to examine possible neurological

effects, auditory brainstem responses (ABR) were measured.
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CHAPTER

III

EXPERIMENTAL PROCEDURE
General Outline of Research
In order to study the effect of dietary intake on the in vivo
methylation processes of inorganic mercury as well as the neurotoxic
effect of methylmercury, three phases of investigation were conducted.
Initially, the diets of guinea pigs were altered to include high levels
of vitamin 812 , folate, and/or vitamin C.

The effect of megavitamin

ingestion on the methylation of mercury in various tissues of these
animals was then examined.

Next, the effect of dietary sulfur amino

acid content on mercury metabolism was studied in rats by diet
supplementation with methionine or cysteine.

Finally, auditory

brainstem evoked responses were used to study the neurotoxic effects of
mercury metabolism and how these effects could be possibly altered by
various dietary manipulations.
Preparative and Analytical Instrumentation
All reagents were analytical grade and specially selected for their
low mercury content.

Glassware was cleaned with nitric acid (4M) and

rinsed with demineralized water.

All solutions were prepared using

demineralized water only.
Tissue homogenization was done on ice using a Brinkmann polytron
homogenizer (Brinkmann Instruments, Inc., Westbury, N.Y.).

All mercury

assays were performed using 300 ml Wheaton Biological Oxygen Demand
(8.0.D.) bottles.

A controlled-temperature, water bath shaker
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(Precision Scientific Company, Chicago, IL.) was employed for tissue
digestion.
Subsequent mercury determinations were carried out by cold-vapor
atomic absorption spectrometry.

Absorption was measured with a

Perkin-Elmer Model 3030 atomic absorption spectrophotometer equipped
with a mercury, hollow cathode lamp.

A cold-vapor apparatus was

laboratory assembled according to directions provided by a Perkin-Elmer
representative (personal communication) with an absorption cell (100 mm
X 20 mm i.d.) used for the AAS measurements.

The gas was first passed

through an absorption cell (50 mm X 20 mm) containing potassium
persulfate (Baker Chemical Company, Phillipsburg, N.J., Analytical
Grade) which dried the material.

After each measurement, the mercury

was adsorbed in a carbon absorption tube (65 mm X 35 mm i.d.) which was
connected to the apparatus with a bypass arrangement.

The system was

closed by means of a peristalic pump.
Animal Model
A pilot study was initially conducted to determine whether rats or
guinea pigs would be best suited for the megavitamin portion of this
study.

It was determined that folacin and vitamin B12 play a more

active role in the guinea pig than in the rat.

This is possibly due to

the fact that the guinea pig requires these vitamins for regeneration of
methionine while the rat has a more active choline oxidase system (82).
Consequently, the guinea pig accumulates more folacin and vitamin B12
than the rat with a dietary excess (83).

A total of 55 male guinea pigs

weighing approximately 250 grams were purchased from Hilltop Laboratory
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Animals, Inc. (Scottdale, PA) and maintained on a 12-hour light-dark
cycle in a controlled temperature environment.
Vitamin Preparation
Vitamin 812 and folic acid were purchased from ICN 8iomedicals,
Inc., Cleveland, OH, while L-ascorbic acid was obtained from Sigma
Chemical Company, St. Louis, MO.

Each vitamin was weighed and

subsequently triturated with sucrose to a total weight of 500 g, which
gave a final concentration of 4 mg folic acid, 50 µg 812 , and 1.8 g
ascorbic acid per 4 g of triturate.

This was then added to ground

guinea pig chow at a concentration of 4 g/100 kg.

The various vitamin

combination mixtures and individual vitamin supplements were derived by
adjusting the amount of sucrose so that vitamin concentrations remained
constant.

The control diet was prepared by adding sucrose at a

concentration of 4 g/100 kg ground chow.
Dietary Regime
Vitamin treatment.

Eight groups of five guinea pigs each were fed

Purina Guinea Pig Chow 5025 and megadoses of vitamin B12 , folate, and/or
vitamin C.

The control diet consisted of animals fed ad libitum chow

which contained all vitamins at levels required for normal guinea pig
nutriture.

One group of animals was fed a diet supplemented with

megadoses of vitamin 812 , folate, and vitamin C.

This group was

referred to as the all vitamin treatment animals.

Three groups of

animals were provided diets which included megadoses of either 812 and
folate, 812 and vitamin C, or folate and vitamin C.
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These groups served

as the combination vitamin treated animals and were referred to
according to their respective vitamin blends.

Finally, three groups of

guinea pigs were given diets supplemented with the individual vitamins.
These groups were called by the respective vitamin treatment, i.e. B12
only, folate only, vitamin Conly.
total of eight weeks.
animals.

All diets were fed ad libitum for a

Distilled water was freely available to all

Two groups of guinea pigs were weighed weekly to assure proper

weight gain and feed consumption with vitamin treatment.

Otherwise, all

animals were housed in groups in polycarbonate cages with stainless
steel wire lids and a raised wire floor with hardwood chip bedding.
Methionine and cysteine supplementation.

Three groups of five

each weaning-age (45-60 g bw.), male Sprague-Dawley rats (Taconic Farms,
Germantown, N.Y.) were fed their respective diets for a 17 day dietary
period.

Animals were fed ad libitum one of three different 15%

casein-based diets: 1) unsupplemented; 2) ·supplemented with 0.625%
methionine; or 3) supplemented with 0.505% cysteine as shown in Table I
(84). Distilled water was readily available and the animals were housed
individually in galvanized wire-bottom cages.
Mercury Treatment
At the end of the dietary period, each animal was given 0.6 mg
HgC1 2/kg body weight as a subcutaneous injection in isotonic saline
every other day for nine doses (85).

Animals were observed throughout

this treatment period for overt signs of mercury toxicity.

Twenty-four

hours after the last injection, the animals were sacrificed and their
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Table 1.

Composition of Methionine or Cysteine Supplemented Diets

Dietary
Constituent
Casein
Sucrose
Cornstarch
Vegetable Oill
Vegetable Short~ning2
Vitamin Mixtur~
Basal Salt Mix
CaC03
CaS04-2H205
Methionine
Cysteine
Non-nutritive bulk6

Unsupplemented
g/lOOg

Methionine
g/lOOg

15
30
30
2
6
2
1.34
1.32
0.04

15
30
30
2
6
2
1.34
1.32
0.04
0.625

12.3

11. 7

Cvsteine
g/lOOg
15
30
30
2
6
2
1.34
1.32
0.04
0.505
11.8

lwesson Oil -- Hunt-Wesson Foods, Inc.
2crisco -- Proctor and Gamble.
3Nutrition Biochemicals Corporation, Cleveland, Ohio. Vitamix
diet fortification mixture was formulated to supply the following
amounts of vitamins (g/kg vitamin premix): thiamin hydrochloride, 1.0;
riboflavin, 1.0; niacin, 4.5; p-aminobenzoic acid, 5.0; calcium
pantothenate, 3.0; pyridoxine hydrochloride, 1.0; ascorbic acid, 45.0;
inositol, 5.0; choline chloride, 75.0; menadione, 2.25; biotin, 0.020;
folic acid, 0.090; vitamin B12, 0.00135; a-tocopherol, 22.0; vitamin A,
1.8; vitamin D, .125; and sufficient glucose to make 1 kg.
4Formulated to contain the following amounts of minerals (g/500g
salt mixture): magnesium carbonate, 33.7; sodium chloride, 77.4;
potassium chloride, 125.4; potassium monobasic phosphate, 237.8; ferric
phosphate, 23; potassium iodide, 0.090; sodium fluoride, 0.01;
manganese chloride, 0.45; aluminum potassium sulfate, 0.019; cupric
acetate, 0.810 and zinc carbonate, 4.8.
5caS04-2H20 provided 0.02% S04=.
6Alphacel -- ICN Biochemical.
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liver, spleen, heart, kidneys, lungs, and brain were removed and frozen
at -80°C for subsequent mercury determinations.
removed from the thigh of the hind leg.

Muscle tissue was also

In addition, hair samples were

taken from the guinea pigs and blood samples were taken from several
treatment groups.

However, blood, muscle, and hair tissues were not

analyzed in rats.
Animal Sacrifice and Tissue Preparation
Guinea pigs were anesthetized with a 10 ml interperitoneal
injection of 1% Brevital Sodium (Eli Lilly and Co., Indianapolis, IN)
and decapitated with shears.
tubes and stoppered.

Blood was immediately collected in test

Rats were stunned by a blow to the back of the

head and decapitated with shears.

Selected tissues were rapidly excised

from all animals, placed in storage containers on ice, and subsequently
stored at -80°C.

Hair samples were also taken from the back of the

guinea pigs' necks and stored.
Upon thawing, a 25% (w/v) homogenate was prepared for each tissue,
except blood and hair, using 1.5 M potassium hydroxide (w/v). Mercury
has been shown to be stable in alkaline media over extended periods and
alkali is more effective than acid in the hydrolyzation of protein (86).
The majority of methylmercury (more than 90%) and approximately 50%
of metallic mercury in the blood has been found within the erythrocytes
(87).

Additionally, it has been reported that determination of mercury

in blood samples can be difficult due to low concentrations (88).
Therefore, blood samples were thawed and homogenized without dilution
until a uniform solution was obtained.
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This was the form used for

subsequent mercury analysis and reflected all blood sample
constituents.
Hair has been shown to accumulate and retain mercury over the life
of the hair fiber.

Thus, it is an excellent retrospective indicator of

mercury in cases of acute poisoning as well as prolonged uptake of low
concentrations of mercury compounds (14,89). In the present study, a
weighed sample of 0.25 g hair was used for mercury analysis.
Selective Determination of Inorganic Mercury and Methylmercury by
Cold-Vapor Atomic Absorption
One of the major problems in mercury analysis is the need to
destroy the organic material and release the mercury from the sample
(4,86).

A number of methods exist for the destruction of organic

materials (4,86,90,91).

However, techniques requiring the digestion of

samples do not enable inorganic mercury and methylmercury to be
distinquished (86,90-97).

Consequently, many methods have been proposed

which involve the extraction of methylmercury using benzene and/or
toluene (24,98-101).

However,

experimentation in this lab resulted in

the conclusion that these methods could not be used by atomic
absorption, as benzene and toluene gave falsely high readings.
Experiments in which labelled mercury compounds were used have shown
that inorganic mercury can be selectively determined in the presence of
organomercurials by its selective reduction with tin (II) chloride
(102).

Magos et al. (88,103) discovered that the rate of methylmercury

reduction and other organomercurials by tin (II) chloride can be made
identical to that of inorganic mercury.

This can be done if the amount

of tin (II) chloride is above a certain level and a cadmium salt is
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added to the reaction mixture.

Thus, a method was developed so that

inorganic mercury can be released first, followed by the release of
methylmercury from the same sample (88,103).
The method used in this research was adapted from several sources
(14,104-108) and allows for selective reduction of inorganic mercury and
methylmercury using the same sample.

These two measurements were then

added together to determine total mercury concentration.
Mercury standard solutions.

A mercury (-II) stock solution was

prepared by dissolving 0.6767 g HgC1 2 (Fisher Scientific Company,
Memphis, TN., Analytical Grade) in 0.05 Msulfuric acid and diluting to
100 ml volume with the same acid solution. This yielded a concentration
of 1.000 mg Hg/ml.

From this solution,

a working standard was prepared

by diluting with acid solution to provide a total concentration of 0.4
µg Hg/ml.

The methylmercury stock solution (500 µg/L) was prepared by
dissolving 62.58 mg CH 3 HgCl (Pfaltz & Bauer, Inc., Waterbury, CT) in 100
ml of 95% ethanol.

The working standard was prepared by diluting with

demineralized water and yielded a final concentration of 0.5 µg
CH 3Hg/ml.
Reagents.

Solutions of 1% (w/v) L-cysteine, 1% sodium chloride,

and 45% sodium hydroxide were prepared by dissolving these compounds in
appropriate amounts of demineralized water.

An 8 M sulfuric acid

solution was also prepared using demineralized water.

These were all

analytical grade reagents which had been tested for mercury content by
the manufacturer.
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A 10% (w/v) tin (II) chloride solution was prepared by dissolving
SnCl 2

•

2H2 0 (Baker Chemical Company, Phillipsburg, N.J., Hg content<

0.5 ppm) in dilute HCl solution (100 ml concentrated HCl/L).

This was

prepared fresh daily.
The tin (II) chloride - cadmium (II) chloride solution was prepared
by dissolving 25 g of SnC1 2

•

2H 20 and 5 g CdC1 2

•

2.5H 20 (American

Scientific Company, Stone Mt., GA) in 50 ml of dilute HCl. The solution
was then heated and mixed until it was clear.

This solution was also

prepared fresh daily.
Procedure.

Representative samples of each tissue

homogenate were

pipetted to 8.0.D. bottles: 5 ml of liver and muscle; 2.5 ml of brain,
lungs, and heart plus 2.5 ml of 1.5 MKOH; 1.0 ml of kidney and spleen
plus 4.0 ml of 1.5 MKOH; 1 ml of blood plus 5 ml of 1.5 MKOH; and 0.25
g weighed hair sample plus 5.0 ml of 1.5 MKOH.

Then, 1 ml of 1%

cysteine and 1.24 ml of 12 N sodium hydroxide were added to each
reaction vessel.

At all times, a total of 22.4 meq of hydrogen

ions was maintained in each sample solution.
in a water-bath at 85°C for five minutes.

The samples were digested

After digestion, the samples

were immediately placed in an ice bath and 12.76 ml of 1% sodium
chloride were added to each bottle.

Total reaction volume was 20 ml and

all samples were maintained on ice until AAS was performed.
Approximately 30 minutes before the start of a run, the atomic
absorption spectrophotometer was switched on and the absorption reading
verified at 253.7 nm.

At the beginning of each run, inorganic mercury

standards were run by adding 1 ml of 10% stannous chloride solution and
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absorption values read.

Also, absorption was determined for the

methylmercury standard.
Each 8.0.D. bottle containing the digested sample was placed in a
ice water bath under the aerator tube assembly.

The following were

added in sequence; 1-2 drops Antifoam A Emulsion (Sigma Chemical
Company, St. Louis, MO), 10 ml of 8 M sulfuric acid, 1 ml of 10% tin
(II) chloride solution, 20 ml of 45% sodium hydroxide, and 50 ml of
demineralized water.

The aerator was immediately attached, the pump

turned on, and the air flow was continued through the reaction vessel
for exactly one minute.
mercury was read.

At this time the absorption peak for inorganic

The aerator tube was immediately removed from the

sample and the air flow switched to remove the mercury through the
activated charcoal chamber.

The pump was allowed to run for a maximum

of one minute or until absorption was zeroed, at which time the air flow
was stopped.
Exactly two minutes after the first reduction process was begun, 10
ml of 8 M sulfuric acid, 2 ml of tin (II) chloride - cadmium chloride
reagent, and 20 ml of 45% sodium hydroxide were added sequentially to
the sample.
switched on.

The aerator tube was attached immediately and the pump was
The reaction was allowed to occur until a maximum

absorption peak for methylmercury was obtained and recorded.

At the end

of the run, the air flow was again diverted through the charcoal
absorption tube to remove all mercury.
The concentrations of inorganic mercury and methylmercury were
subsequently calculated using the standard solution concentrations and
absorption values.

All samples were run in duplicate and extreme
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variations (over 5%) in measurements resulted in repeated assay of the
sample.
Auditory Brainstem Response (ABR) Testing
Preyor's reflex was performed on all animals midway through mercury
treatment and immediately before ABR testing was conducted.

This

consisted of visual observation of ear twitching in response to a loud
noise.
All ABR recordings were obtained in a quiet room.
anesthetized with isoflurane.

Animals were

Recording electrodes were placed

subcutaneously at the vertex and over the mastoid of the right ear and a
ground electrode was inserted into the nap of the neck.

Active

electrode impedence was controlled below 10 kn and normally was within
1 kn of a reference electrode.

The right ear was tested with pure tones

while the left ear received white noise which was 30 dB SPL (sound
pressure level) less than the testing signal.

Potentials were evoked

using pure tones of alternating polarity at a rate of 11.4/sec.

The

potential difference between the vertex and the mastoid electrode
ipsilateral to the stimulated ear was amplified and band-passed at
150-3000 Hz.

Responses (10 msec) to 256 stimuli were averaged to

produce each ABR and a repetition of each stimulus paradigm condition
was made to assess reproducibility.

A total of four stimulus

frequencies (8k, 6k, 4k, and 2k) were used beginning at an intensity of
105 SPL and decreasing in 10 dB steps until close to threshold and then,
5 dB steps to threshold.

Following each experiment, the animals were
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given an otoscopic examination to assure that the ear canal was free of
cerumen.
After all tests were completed, hard copies of each recording were
made.

Four to 5 peaks of the averaged signal were identified and

labeled with Roman numerals.
the III and IV latency range.

In most cases, only one wave occurred in
Therefore, no value was recorded for wave

IV and the single wave (III and IV complex) was labeled as wave III.
Wave latencies were measured for waves I, II, and V with latency defined
as the time from stimulus onset to the positive peak of each wave.
These measurements were recorded to the nearest 0.01 msec.

The

amplitude of each wave was determined by measuring from its peak
positivity to the following negative trough.
recorded to the nearest 0.01 µV.

These measurements were

Interpeak latency (IPL) was derived by

subtracting the wave I latency from the wave V latency.

In addition,

thresholds were determined by the appearance of peak I as an indicator.
Statistical Analysis
All data were evaluated by Analysis of Variance (ANOVA) performed
with SAS (SAS Program, University of Tennessee) using the General Linear
Model (GLM) procedures.

Differences between groups for each tissue were

determined by Duncan's multiple-range test (109).
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CHAPTER IV
RESULTS
This research project consisted of three separate investigations.
First, several groups of guinea pigs were fed either a control diet or a
diet which included megadoses of vitamin 812 , folate, and/or vitamin C
in various combinations.

After eight weeks on the diet regime, these

animals were given an injection of mercuric chloride every other day for
a total of nine injections, sacrificed, and tissues removed.
tissue was then analyzed for inorganic and methyl mercury.

Each
Total

mercury and the percent inorganic and methyl mercury were subsequently
determined.

Weight/growth data were obtained for one group of guinea

pigs fed either a control or 812/folate diet.

This information is

charted on Figure 4 and the measurements are shown in Appendix 1.

These

data indicated that both groups had consistent weight gain, therefore;
difference in growth was not a factor in the mercury data analysis.
Also after mercury injections were begun, a slight weight loss was
observed in both groups which is a phenomenon reported by a number of
researchers (32,51,54,57).
Since methionine is also a potential methyl donor in mammals, a
second aspect of this research was to investigate the effect of
methionine or cysteine on mercury metabolism in rats.

These animals

were fed either a control diet, or methionine or cysteine supplemented
diet for seventeen days, then given mercury injections every other day
for a total of nine injections.

After sacrifice, the tissues from these
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animals were also analyzed for inorganic and methyl mercury with
subsequent determination of total and percent mercury.
Finally, several groups of guinea _pigs treated with megavitamins
and mercury were tested for auditory brainstem responses (ABR).
Following ABR evaluation the animals were sacrificed and tissue mercury
analysis performed.

The ABR data were used to examine the neurotoxicity

of mercury.
The results reported here are divided into guinea pig data, rat
cysteine/methionine data, and ABR analysis.

Additionally, the guinea

pig data are further divided into controls versus all vitamin dietary
regime, controls compared to various vitamin combinations, and controls
versus animals treated with megadoses of the individual vitamins.
Controls vs All Vitamins
A total of eight tissues were analyzed for inorganic and
methylmercury.
levels.

These values were added together to derive total mercury

Percent values were also calculated.

Table 2.

The results are shown on

There were several trends observed between the two groups.

Inorganic mercury was higher in the heart (1.29 µg vs .72 µg) and
lungs (.82 µg vs .74 µg) in the vitamin treated group compared to
controls.

However, inorganic mercury was lower in the liver (.52 µg vs

.78 µg), muscle (.10 µg vs .21 µg), brain (.19 µg vs .30 µg), spleen
(.52 µg vs .89 µg), kidney (16.96 µg vs 19.17 µg) and hair (.73 µg vs
.80 µg) in the vitamin group compared to controls.
Methylmercury tended to follow the same trends as the inorganic
form.

It was lower in the vitamin group than controls in the liver
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Table 2.

Mercury Levels in Various Tissues of Guinea Pigs with the All-Vitamin Dietary Regime

µg Hg/g wet tissue
Inorganic Hg

Methyl Hg

Total Hg

Liver
Controls (n=l8)
Vitamins (n=8)

.78 ± .28
.52 ± .12

.37 ± .20
.25 ± .03

1.15 ± . 46
.77 ± .14

69
67

31
33

Muscle
Controls
Vitamins

.21 ± .27
.10 ± .02

.18 ± .14
.13 ± .09

.39 ± .38
. 23 ± .10

51
47

49

Brain
Controls
Vitamins

.30 ± .17
.19 ± . 06

.24 ± .15
.18 ± .07

.54 ± .31
.37 ± .11

56
51

44

Heart
Controls
Vitamins

.72 ± .61
1.29 ± .91

.35 ± .19
.60 ± .33

1.07 ± .76
1.90 ± 1.24

63
66

37
34

Lungs
Controls (n=l3)
Vitamins

.74 ± .18
.82 ± .16

.40 ± .07
.41 ± .07

1.14 ± .22
1.23 ± .21

65
67

35
33

Spleen
Controls
Vitamins

.89 ± .51
.52 ± .10

.59 ± .20
.41 ± .10

1.48 ± .69
.93 ± .18

58
56

42
44

Kidney
Controls
Vitamins

19.17 ± 2.49
16.96 ± .75

33.89 ± 4.49
30. 42 ± 1. 44

57
56

43
44

Treatment

U1
0

14.72 ± 2.11
13. 46 ± .80

%

Inorganic

% Methyl

53
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Table 2.

(Continued)

u g Hg/g wet tissue
Treatment
Hair
Controls (n=13)
Vitamins

Inorganic Hg

Methyl Hg

Total Hg

% Inorganic

% Methyl

.80 ± .26
.73 ± .33

.65 ± .23
.70 ± .25

1.44 ± .47
I. 43 ± . 48

55
51

45
49

Values represent the average± S.D.
statistically different from controls.

.....
(J'1

The data for the all-vitamin treated group was not

(.25 µg vs .37 µg), muscle (.13 µg vs .18 µg), brain (.18 µg vs .24 µg),
spleen (.41 µg vs .59 µg) and kidney (13.46 µg vs 14.72 µg), while it
was higher in the heart (.60 µg vs .35 µg) and the lungs (.41 µg vs .40
µg).

The only exception was found in hair tissue, which contained a

higher methylmercury content in the vitamin groups (.70 µg) compared to
controls (.65 µg).
The vitamin group exhibited lower total mercury concentrations in
the liver (.77 µg vs 1.15 µg), muscle (.23 µg vs .39 µg), brain (.37 µg
vs .54 µg), spleen (.93 µg vs 1.48 µg), kidney (30.42 µg vs 33.89 µg),
and hair (1.43 µg vs 1.44 µg) compared to controls.

Total mercury

tended to be higher in the vitamin group than controls in the heart
(1.90 µg vs 1.07 µg) and the lungs (1.23 µg vs 1.14 µg).
Interestingly, tissues from the vitamin group that had lower
mercury concentrations had a higher percent of mercury as methylmercury.
For example, the percent methylmercury in the liver (33% vs 31%), muscle
(53% vs 49%), brain (49% vs 44%), spleen (44% vs 42%), kidney (44% vs
43%), and hair (49% vs 45%) was higher in the vitamin treated group
compared to controls.

Both the heart and lungs had lower percent

methylmercury for vitamins versus controls (34% vs 37%, and 33% vs 35%,
respectively).
As noted, there were a number of trends exhibited between the
vitamin treated group and control animals.

However, these differences

were not statistically significant in any of the tissues analyzed.
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Controls vs Vitamin Combinations
The results from five tissues are shown in Table 3.

In the liver

there was no statistical difference found between controls, 812/vitamin
C and folate/vitamin C for inorganic, methyl, and total mercury, as well
as percent inorganic and methylmercury.

The 812/folate group was

significantly higher than controls for inorganic mercury (1.05 µg vs .78
µg), methylmercury (.67 µg vs 37 µg) and total mercury (1.72 µg vs 1.15
µg).

Also the percent methylmercury was higher (p < 0.05) in the

812/folate group (40%) compared to controls (31%).

In addition, the

812/folate group had values which were significantly greater than the
812/vitamin C group for inorganic, methyl, total, percent inorganic, and
percent.methylmercury, but had statistically different values from the
folate/vitamin C group for only methylmercury concentration.
There were no differences between the control, 812/folate, and
812/vitamin C groups for the various mercury concentrations and percent
measurements in muscle.

The folate/vitamin C group was statistically

different from the controls and the other combination groups for
inorganic, methyl and total mercury concentrations, but was not
different in percent inorganic or percent methylmercury for this tissue.
Interestingly, the two 812 groups (8 12/folate and 812/vitamin C) showed a
higher percent methylmercury (61% and 57%, respectively) compared to the
control and folate/vitamin C groups (49% and 50% respectively).
However, this difference was not statistically significant.
In the brain, no differences were observed between controls and the
vitamin combinations for inorganic, methyl or total mercury.

The

812/vitamin C group had a higher (p < 0.05) percent of mercury as
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Table 3.

Mercury Levels in Various Tissues of Guinea Pigs with the Vitamin Combination Dietary
Regime

ug Hg/g wet tissue
Treatment

(J'1
~

ln~rganic Hg

Methyl Hg

Total Hg

% Inorganic

% Methyl

Liver
Controls
812/Folate
B1fVitamin C
Fo ate/Vitamin C

.78
1.05
.61
. 78

±
±
±
±

.28a,b
.25a
.o9b
.10a, b

.37
.67
.27
.38

±
±
±
±

.20~
.09
.o4a
.01a

1.15
I. 72
.88
1.15

±
±
±
±

.46a,b
.33~
.13
.10a,b

69a
6ob,c
69a
67a,b

40 ,c
31a
33a,b

Muscle
Controls
812/Folate
B1fVitamin C
Fo ate/Vitamin C

.21
.12
.27
1.33

±
±
±
±

.21a
. 03a
.29ab
1.60

.18
.19
.31
.83

±
±
±
±

.14a
.o4a
.19~
.83

.39
.31
.58
2 .16

±
±
±
±

.38a
.o4a
_45a
2. 40b

51a,b,c
39b
43a,b
5oa,b,c

49a,b,c
61b
57b,c
5oa,b,c

Brain
Controls
812/Folate
B1fVitamin C
Fo ate/Vitamin C

.30
.16
.20
.25

±
±
±
±

.I7a
.02a
.o8a
.o9a

. 24
.15
.29
.18

±
±
±
±

.15a
. 03a
.14a
.oga

.54
.31
.49
.43

±
±
±
±

.31a
.o4a
.22a
.14a

56a,b
51b
41c
58a,b

44a,b
49a
59c
42a,b

Heart
Controls
812/Folate
B1fVitamin C
Fo ate/Vitamin C

.72
.26
.44
.84

±
±
±
±

.61a,b
.o3b
.31b
. 73a, b

.35
.33
.23
.39

±
±
±
±

.19~,b
.19b
.12 b
.26a,

1.07
.59
.67
I. 23

±
±
±
±

.76a,b
.2ob
_43b
. gga' b

63a
48b
63a
64a

37a
52b
37a
36a
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Table 3.

(Continued)

µq Hq/q wet tissue
Treatment
Lungs
Controls
B12/Folate

U'1
U'1

Inorganic Hg

Methyl Hg

.74 ± .I8a
. 69 ± .18a

Total Hg

%

Inorganic

% Methyl

.40 ± .01a
.40 ± .01a

1.14 ± .22~,b
1.10 ± .19

55a,b
53b

35a,b
37a

Spleen
Controls
812/Fo late
B1(Vitamin C
Fo ate/Vitamin C

.89
.70
1. 42
1.39

±
±
±
±

.51~,b
.13
1. ooa, ~
1.oaa,

.59
.54
.76
.67

±
±
±
±

.2oa,b
.05a,b
.46b,c
.37a,b,c

1.48
1.24
2.18
2.06

±
±
±
±

.69a,b,c
.11a,b
l.46b,c
l.45a,b,c

5aa,b
55b
54a
55a

42a,b
44a
35b
35b

Kidney
Controls
B12/Folate
B1(Vitami n C
Fo ate/Vitamin C

19.17
20.46
17.91
18.30

±
±
±
±

2.49a,b
2.43a
.56a,b
2.ooa,b

14.72
16.92
14.11
14.77

±
±
±
±

2.11a,b
1.61c
.a2a,b
1.42a,b

33.89
37.38
32.02
33.07

±
±
±
±

4.49a,b,c
4.0lc
l.33a,b
3.3oa,b,c

57a
55a,b
55a,b
55a,b

43a
45a,b
44a,b
45a,b

Hair
Controls
B12/Folate

.80 ± .26a
.87 ± .2oa

.65 ± .23a b
.78 ± .o8a,

1.44 ± .46a b
.165 ± .25a,

55a
53a

45a
47a

Blood (µg Hg/ml)
Controls
B12/Folate

.19 ± .04a,b
.18 ± .o3a

.18 ± .o5a b
.17 ± .02a,

.37 ± .09~,b
.35 ± .03

53a
51a

47a
49a

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

methylmercury compared to controls and the other vitamin combinations.
The percent inorganic mercury also reflected this difference.
Controls were not statistically different from all the vitamin
combinations for inorganic, methyl, and total mercury concentrations in
the heart.

However, the B12/folate group had a significantly higher

percent methyl (52%) measurement compared to controls (37%), the
B12/vitamin C group (37%) and the folate/vitamin C group (36%).

A trend

was noted in this tissue in which the two B12 groups exhibited the
lowest mercury concentrations (inorganic, methyl, and total), while the
folate/vitamin C group tended to have the highest concentrations.
Only one vitamin combination was studied in lung tissue.

There was

no difference in mercury concentrations or percent mercury with
B12/folate compared to controls.
In the spleen, no difference was observed between the controls and
.the various vitamin combinations for mercury concentration and percent
mercury.

The B12/folate group had significantly higher percent

methylmercury (44%) compared to the B12/vitamin C (36%) and
folate/vitamin C groups (35%).

Interestingly, the two vitamin C groups

exhibited a trend of higher mercury concentrations and percent inorganic
mercury as compared to controls and the B12/folate group.
In the kidney, no difference in inorgan~c mercury and percent
mercury was shown for the vitamin combinations and controls.

The

B12/folate group had a significantly higher methylmercury concentration
(16.92 µg) than control (14.72 µg), B12/vitamin C (14.11 µg), and
folate/vitamin C (14.77 µg) groups.

In addition, the B12/folate group

had significantly more total mercury (37.38 µg) compared to the
56

B12/vitamin C group {32.02 µg).

While this group exhibited an apparent

increase in total mercury as compared to controls {33.89 µg) and the
folate/vitamin C group {33.07 µg), this difference was not statistically
significant.
Hair and blood were evaluated for the control and B12/folate groups.
Mercury concentrations and percent mercury were not significantly
different in either of these tissues for the two groups.
Controls vs Individual Vitamin Treatment
The results from the experiments done to examine the effect of
megadoses of B12 , folate, or vitamin Con mercury metabolism are shown
in Table 4.

In animals treated with the vitamins separately, the

concentrations of all forms of mercury in the liver were significantly
higher than the controls.

Additionally, the percent methylmercury was

greater {p < 0.05) in the B12 only, folate only, and vitamin Conly
treated groups compared to controls.

The percent inorganic mercury was

lower in the individual vitamin groups compared to controls and this
difference was statistically significant.
In muscle there was no statistical difference in mercury
concentrations {inorganic, methyl, and total) between the vitamin
treated groups and controls.

However, in the vitamin C group, the

percent inorganic mercury was higher and percent methyl lower than
control animals.

These differences were statistically significant.

There was also a tendency for the vitamin treated animals to have lower
concentrations of all forms of mercury.
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Table 4.

Mercury Levels in Various Tissues of Guinea Pigs with the Individual Vitamin Dietary Regime
µg Hg/g wet tissue

Treatment
Liver
Controls
B1t
Fo ate
Vitamin C

0,

co

Inorganic Hg
.78 ± .28a,b
1. 58 ± . 20c
1. 60 ± . 71 C
1.72 ± .54c

Meth~l Hg
.37
1.16
1. 22
1. 08

±
±
±
±

.20a
. 40c
. 27c
. J 9C

Total Hg
1.15 ± .46a,b
2.74 ± _57c
2.83 ± .90C
2.79 ± .54c

%

Inorganic

%

Meth~l

69a
59c
55c
51b,c

31a
41c
44c
39b,c

51a,b,c
55a,c,d

Muscle
Controls
B1t
Fo ate
Vitamin C

.21
.18
.15
.16

±
±
±
±

.27a
.o4a
. 04a
.o3a

.18
.14
.10
.07

±
±
±
±

.14a
.02a
.o4a
.02a

.39
.32
.25
.24

±
±
±
±

.38a
.o4a
.o7a
.o3a

6QC,d

49a,b,c
45a,c,d
4oa,d

69d

31d

Brain
Controls
B1t
Fo ate
Vitamin C

.30
.27
.30
.23

±
±
±
±

.17a
.04a
.osa
.o3a

.24
.19
.18
.19

±
±
±
±

.15a
.o3a
.02a
.02a

.54
.46
.48
.42

±
±
±
±

.3la
.o3a
.o4a
.o4a

55a,b
saa,b
53a
55a,b

44a,b
42a,b
37b

Heart
Controls
B1t
Fo ate
Vitamin C

.72
.32
.31
.28

±
±
±
±

.61a,b
.o4b
.o6b
.o6b

.35 ± .19a,b
.17 ± .04b
.13 ± .01b
.14 ± .04b

1.07 ±
.so±
.45 ±
.42 ±

.76a,b
.o6b
.osb
.o6b

53a
55a
70a
66a

37a
35a
30a
34a

Lungs
Controls
B1t
Fo ate
Vitamin C

.74
1.01
.86
.90

.40 ± .o7a
. 42 ± .10a
.32 ± .o3a
.40 :t .lla

1.14
1.43
1.18
1.29

55a,b
7oc,d
73d
69 a,b,c

35a,b
3oc,d
27d
31 b,c,d

± .18a
± .3ob
± .10a,b
± .2sa,b

± .22a,b
± .38a
± .12a,b

± _35a,b

44a,b

Table 4.

(Continued)

µg Hg/g wet tissue
Treatment
Spleen
Controls
B1f
Fo ate
Vitamin C

<.11

\0

Inorganic Hg
.89 ± .51a,b
1.73 ± .53a
1.39 ± .98a,b
l.75±1.16a

Kidney
Controls
B1f
Fo ate
Vitamin C

19.17
19.08
18.60
20.12

Hair
Controls
B1f
Fo ate
Vitamin C

.80
.95
.95
.95

± .2oa
± _34a

Blood (µg Hg/ml)
Controls
B1f
Fo ate
Vitamin C

.19
.24
.20
.28

± .04a,g
± .05a,
± .02a,b
± .04b

± 2.49a,b
± l.65a,b
± l.69a,b
± .88a
± .26a
± .32a

Total Hg

Meth~l Hg
.59
.91
.81
.93
14.72
15.84
15.57
15.94

±
±
±
±

.2oa,b
.18~
.24 ,c
.35c

1.48 ± .69a,b,c
2. 64 ± . 70c
2.21 ± 1.22b,c
2. 68 ± 1. 51 C

± 2.1 a,b 33.89 ± 4.49a,b,c
± .34 ,c 34.91 ± l.9oa,b,c
± .88b,c 34.16 ± 2,54a,b,c

6

± .67b,c

.65
1.27
1. 84
1.47

±
±
±
±

.23a
.63a,b,c
1. 3gc
.88 ,c

.18
.15
.13
.16

±
±
±
±

. 05a
.02a,b
.01b
.01a,b

Values represent the average± S.D.
significantly different (p > 0.05).

% Inorganic

36.07 ± 1.11b,c
1.44
2.22
2. 79
2.43
.37
.38
.33
.44

±
±
±
±

,47a .
.87a,b,c
1. 35c
,93b,c

± .09a,b
± .07a,b
± .02b
± .osa

% Meth~l

58a,b
55a
5oa,b
53a,b

42a,b
35b
4oa,b
37a,b

57a
54b
55b
55a,b

43a
45b
45b
44a,b

55a
44a,b
40b
43a,b

45a
55a,b
60b
57a,b

53a
61b
60b
54a

47a
39b
40b
35b

Data sharing a common subscript letter in a column are not

No difference in mercury concentrations and percent mercury was
observed with vitamin treatment in the brain tissue compared to
controls.

However, there was a tendency for the vitamin groups to have

lower concentrations of mercury.
The heart also did not exhibit a statistically significant
difference in mercury concentration or percent mercury between the
vitamin treated groups and controls.

However, the concentration of

inorganic, methyl, and total mercury tended to be quite a bit lower in
the vitamin treated animals than controls.
The vitamin 812 group had significantly higher inorganic mercury
levels than controls (1.01 µg vs .74 µg respectively) in lung tissue.
This was reflected also in a higher percent inorganic mercury (70%) and
lower percent methyl (30%) for 812 animals versus controls (65%
inorganic, 35% methyl).
significant.

These differences were statistically

Additionally, when expressed as percent the folate group

had significantly mo~e inorganic (73%) and significantly less methyl
(27%).

While the individual vitamin treated animals tended to have higher
inorganic, methyl, and total mercury concentrations than controls in the
spleen, these measurements were not statistically different.

Also, the

percent inorganic mercury tended to be elevated in vitamin treated
animals, but was not statistically different from controls.
In the kidney there was no difference in mercury concentrations
with vitamins given separately.

These animals tended to show increased

methylmercury and total mercury concentrations when compared to
controls.

The 812 group and folate group had significantly larger
60

percents of mercury present as methylmercury (46% and 45% respectively)
compared to controls (43%).
The concentration of inorganic mercury was not statistically
different for the vitamin group compared to controls for hair samples.
Although these groups tended to have higher methylmercury concentrations
than controls, only the folate and vitamin C groups had significantly
higher.

Additionally, only the folate group had significantly more

mercury as percent methyl (60%) compared to controls (45%).

However,

the 812 (56%) and vitamin C groups (57%) appeared higher than controls.
These differences were inversely reflected in the percent inorganic
mercury.
In the blood there was no difference in concentration for all forms
of mercury, but the vitamin treated animals exhibited an apparent
increase in inorganic mercury concentrations and lower methylmercury
concentrations compared to controls.

When expressed as percent, the

vitamin treated groups had significantly more inorganic mercury
(8 12 = 61%, folate = 60%, and vitamin C = 64%) than controls (53%)
and less methylmercury.
Accumulated Guinea Pig Data
The data from all the various vitamin treatments compared to
controls are displayed by tissue in Tables 5 - 13.

In the liver the

individual vitamin treated groups had significantly more inorganic,
methyl, total and percent methylmercury than controls and all other
treated groups.

The 812/folate group had significantly more inorganic

mercury than the all vitamin and 812/vitamin C groups.
61

Of importance,

Table 5.

Mercury Levels in the Liver Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

µg Hg/g wet tissue
Treatment

N

Meth~l Hg

Total Hg

%

Inorganic

% Meth~l

69a

31a

.77 ± .14b

67a,b

33a,b

.67 ± .ogb

1. 72 ± .33a

6ob,c

4ob,c

.61 ± .ogb

.27 ± .o4a

. 88 ± .13b

69a

31a

. 78 ± .10a, b

.38 ± .01a

1.15 ± .10a,b

67a,b

33a,b

Controls
n=18

.78 ± .28a,b

.37 ± .20a

1.15 ± .46a,b

A11 Vitamins
n=8

.52 ± .12b

.25 ± .o3a

1.05 ± .2sa

812/Vitamin C
n=4
Folate/Vitamin C
n=5

812/Folate
n=5
O'I

Inorganic Hg

B12 Only
n=5

1. 58 ± . 20c

1.16 ± . 40c

2.74 ± .57c

59c

41c

Folate Only
n=5

1. 60 ± . 71 C

1.22 ± .27c

2.83

± .9QC

56c

44c

Vitamin C Only
n=5

1.72 ± .54c

6Ib,c

39b,c

Values represent the average± S.D.
significantly different (p > 0.05).

1. 08 ± .19c

2.79 ± .54c

Data sharing a common subscript letter in a column are not

Table 6.

Mercury Levels in the Muscle Tissue of Guinea Pigs with Different Dietary Vitamin Regimes

µg Hg/g wet tissue
Treatment

O"\

w

Inorganic Hg

Meth~l Hg

Total Hg

%

Inorganic

% Meth~l

Controls
n=l8

.21 ± .21a

.18 ± .14a

.39 ± .38a

51a,b,c

49a,b,c

All Vitamins
n=8

.10 ± .02a

.13 ± .o9a

. 23 ± .10a

47a,b,c

53a,b,c

812/Folate
n=5

.12 ± .o3a

.19 ± . 04a

.31 ± .o4a

39b

61b

812/Vitamin C
n=4

.27 ± .29a

. 31 ± . l 9a

.58 ± .45a

43a,b

57b,c

1. 33 ± 1. 60b

.83 ± .83b

2.16 ± 2.40b

50 a,b,c

5oa,b,c

812 Only
n=5

.18 ± .o4a

.14 ± .02a

.32 ± .o4a

55a,b,d

45 a,b,d

Folate Only
n=5

.15 ± .o4a

.10 ± .o4a

.25 ± .01a

60c,d

4oa,d

Vitamin C Only

.16 ± .o3a

.07 ± .02a

.24 ± .o3a

59d

31d

Folate/Vitamin C
n=5

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 7.

Mercury Levels in the Brain Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

ug Hg/g wet tissue
Treatment

..,:::.
°'

Inorganic Hg

Meth1l Hg

Total Hg

% Inorganic

% Meth1l

Controls
n=18

. 30 ± .17a

.24 ± .15a

.54 ± .31a

55a,b

44a,b

All Vitamins
n=8

.19 ± .o6a

.18 ± . 07a

.37 ± .11a

51b

49a

812/Folate
n=5

.16 ± .02a

.15 ± . 03a

.31 ± .04a

51b

49a

812/Vitami n C
n=4

.20 ± .o8a

.29 ± .14a

.49 ± .22a

41c

59c

Folate/Vitamin C
n=5

.25 ± .oga

.18 ± .oga

.43 ± .14a

saa,b

42a,b

812 Only
n=5

.27 ± .o4a

.19 ± • 03a

.46 ± .o3a

5aa,b

42a,b

Folate Only
n=5

.30 ± .osa

.18 ± .02a

.48 ± .o4a

63a

37b

Vitamin C Only
n=5

.23 ± .o3a

.19 ± .02a

.42 ± .o4a

56a,b

44a,b

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 8.

Mercury Levels in the Heart Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

u g Hg/g wet tissue
Treatment

Inorganic Hg

Meth~l Hg

Total Hg

%

Inorganic

% Meth~l

.35 ± .19a,b

1.07 ± .76a,b

63a

37a

1.29 ± .91a

.60 ± .33a

1.90 ± 1.24a

66a

34a

B12/Folate
n=5

.26 ± .03b

.33 ± .19b

.59 ± .2ob

4ab

52b

B12/Vitami n C
n=4

.44 ± .31b

.23 ± .12b

.67 ± .43b

63a

37a

Folate/Vitamin C
n=5

.84 ± .74a,b

.39 ± .26a,b

1. 23 ± . gga' b

64a

36a

B12 Only
n=5

.32 ± .o4b

.17 ± . 04b

.5o ± .o6b

65a

35a

Folate Only
n=5

.31 ± .o6b

.13 ± .01b

.45 ± .o5b

70a

30a

Vitamin C Only
n=5

.28 ± .o6b

.14 ± .o4b

.42 ± .o6b

66a

34a

Controls
n=18
A11 Vitamins

.72 ± .61a,b

n=B

°'
(J1

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 9.

Mercury Levels in the Lung Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

ug Hg/g wet tissue
Treatment

°'
°'

Inorganic Hg

Meth~l Hg

Total Hg

% Inorganic

% Meth~l

Controls
n=13

.74 ± .I8a

.40 ± .01a

1.14 ± .22a,b

6sa,b

35a,b

A11 Vit am i ns
n=8

.82 ± .16a,b

.41 ± .01a

1.23 ± .21a,b

67a,b,c

33a,b,c

812/Folate
n=5

.69 ± .12a

.40 ± .o9a

1.10 ± .19b

63b

37a

1.01 ± .Job

.42 ± .10a

1.43 ± .38a

70c,d

3oc,d

812 Only
n=5
Folate Only
n=5

.86 ± .10a,b

.32 ± .o3a

1.18 ± .12a,b

73d

27d

Vitamin C Only
n=5

.90 ± .2sa,b

. 40 ± .11 a

1.29 ± _35a,b

69a,c,d

31b,c,d

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 10.

Mercury Levels in the Spleen Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

µg Hg/g wet tissue
Treatment__

O'I
""'-J

Inorganic Hg

Meth~l Hg

Total Hg

% Inorganic

% Meth~l

58a,b

42a,b

. 93 ± .18a

56b

44a

.54 ± .05a,b

1.24 ± .11a,b

56b

44a

2.18 ± l.46b,c

64a

36b

Controls
n=l8

.89 ± .51a,b

.59 ± .2oa,b

A11 Vitamins
n=8

. 52 ± .10b

.41 ± .10a

812/Folate
n=5

. 70 ± .13b

1.48 ± .69a,b,c

812/Vitamin C
n=4

1.42 ± 1.ooa,b

.76 ± .46b,c

Fol ate/Vitamin C
n=5

1.39 ± 1.oaa,b

.67 ± _37a,b,c 2.06 ± 1_45a,b,c

65a

35b

B12 Only
n=5

1. 73 ± • 53a

.91 ± .I8c

2.64 ± .1oc

65a

35b

Folate Only
n=5

1.39 ± .9aa,b

.81 ± .24b,c

2.21 ± 1.22b,c

6oa,b

4oa,b

Vitamin C Only
n=5

1.75 ± 1.16a

.93 ± _35c

2. 68 ± 1. 51 C

63a,b

37a,b

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 11.

Mercury Levels in the Kidney Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

ug Hg/g wet tissue

O'I
CX>

Total Hg

% Inorganic

Treatment_

Inorganic Hg

Controls
n=l8

19.17±2.49a,b

14.72 ± 2.11a,b 33.89 ± 4_49a,b,c

57a

43a

A11 Vitamins
n=8

16.96 ± _75b

13.46 ± .8oa

30.42 ± 1.44a

55a,b

44a,b

B12/Folate
n=5

20.46 ± 2.43a

16.92 ± 1.61c

37.38 ± 4.0lc

55a,b

45a,b

B12/Vitami n C
n=4

17. 91 ± . 55a, b 14.11 ± .82a,b 32.02 ± 1.33a,b

55a,b

44a,b

Folate/Vitamin C
n=5

18.30 ± 2.ooa,b 14.77 ± 1.42a,b 33.07 ± 3.3oa,b,c

55a,b

45a,b

812 Only
n=5

19.08 ± l.6sa,b 15.84 ± _34b,c 34.91 ± l.9oa,b,c

54b

45b

Folate Only
n=5

18.60 ± l.69a,b 15.57 ± .88b,c 34.16 ± 2.s4a,b,c

55b

45b

Vitamin C Only
n=5

20.12 ± .8aa

55a,b

44a,b

Meth~l Hg

15.94 ± .67b,c 36.07 ± 1.17b,c

Values represent the average± S.D.
significantly different (p > 0.05).

% Meth~l

Data sharing a common subscript letter in a column are not

Table 12.

Mercury Levels in the Hair Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

ug Hg/g wet tissue
Treatment

°'
~

Inorganic Hg

Methyl Hg

Total Hg

% Inorganic

% Methyl

Controls
n=l3

.80 ± .26a

.65 ± .23a

1.44 ± .47a

55a

45a

A11 Vitamins
n=8

.73 ± .33a

.70 ± .2sa,b

1.43 ± .48a

51a,b

49a,b

812/Folate
n=5

.87 ± .2oa

.78 ± .o8a,b

1.65 ± .25a,b

53a

47a

812 Only
n=5

.95 ± .32a

1.27 ± .63a,b,c 2.22 ± .81a,b,c

44a,b

55a,b

Folate Only
n=5

.95 ± .2oa

1.84 ± 1.38c

2. 79 ± I. 36c

40b

50b

Vitamin C Only
n=5

.95 ± .34a

1. 41 ± . 99b, c

2.43 ± _93b,c

43a,b

57a,b

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 13.

Mercury Levels in the Blood Tissue of Guinea Pigs with Different Vitamin Dietary Regimes

µg Hg/ml
Treatment

-....J
0

Inorganic Hg

Meth:il Hg

Total Hg

%

Inorganic

% Meth:il

Controls
n=5

.19 ± • 04a, b

.18 ± .o5a

.37 ± .oga,b

53a

47a

812/Folate
n=5

.18 ± .o3a

.17 ± 02a,b

.35 ± .o3b

51a

49a

812 Only
n=5

. 24 ± • 05a, b

.15 ± .02a,b

.38 ± .01a,b

61b

3gb

Folate Only
n=5

.20 ± .02a,b

.13 ± .01b

.33 ± .02b

60b

40b

Vitamin C Only
n=5

.2a ± .o4b

.16 ± .01a,b

.44 ± .o5a

64b

36b

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

are the data showing that the 812/folate group (.67 µg) had a
significantly higher methylmercury concentration than the control (.37
µg), all vitamin (.25 µg), 812/vitamin C (.27 µg), and folate/vitamin C
(.38 µg) groups.

This difference is portrayed in the percent

methylmercury data with the B12/folate group having significantly more
as percent methylmercury compared to controls and the 812/vitamin C
group.
Table 6 shows the data for muscle tissue.

The folate/vitamin C

group had higher (p < 0.05) concentrations of all three forms of mercury
compared to all other groups.

However, the greatest percent

methylmercury level observed was 61% in the 812/folate group, which was
significantly different from the B12 , folate, and yitamin C groups.
Also the vitamin C group had significantly less mercury as percent
methylmercury (31%) compared to all the other groups, except the B12 and
folate groups.
The data for the brain tissue are shown in Table 7.

There were no

differences in the various mercury concentrations for all treatments
versus controls.

However, the B12/vitamin C group did have a

significantly higher proportion of mercury as methylmercury (59%)
compared to controls (44%) and other vitamin treatments.

A trend was

also evident in that the groups treated with B12 and some combination
(all vitamin, B12/folate, or B12/vitamin C) had a higher proportion of
The individual vitamins and

methylmercury values than controls.

fol ate/vitamin C groups all had lower percent methyl values than
controls.
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In the heart (Table 8) there were no differences between controls
and the various vitamin treated groups.

However, the all vitamin group

did have mercury concentrations which were significantly higher than the
other vitamin treated groups, except the folate/vitamin C group.
Furthermore, the 812/folate group had proportionately more methylmercury
(52%) than controls (37%) and the other vitamin treated groups.
Data for lung tissue (Table 9) were fairly consistent between
groups; however, the 812 group had an inorganic mercury level (1.01 µg)
which was significantly greater than controls (.74 µg) and the
812/folate group (.69 µg).

Methylmercury concentrations were not

significantly different between groups.

Although the B12 group had

significantly more (1.43 µg) total mercury than the B12/folate group
(1.10 µg), both the B12 and folate groups had proportionately less
mercury as methylmercury (30% and 27% respectively) than controls (35%)
and the 812/folate group (37%).
Inorganic and total mercury concentrations for the vitamin treated
groups were not statistically different from control animals in the
spleen (Table 10).

The B12 and vitamin C groups did have inorganic and

total mercury concentrations which were greater (p < 0.05) than the all
vitamin group and the 812/folate group.

Also, the B12 and vitamin C

groups had significantly higher methylmercury levels than controls, the
all vitamin, and B12/folate group.

Both the all vitamin and B12/folate

groups had 44% methylmercury levels which were statistically different
from the 812/vitamin C group (36%), folate/vitamin C group (35%) and the
812 only group (35%).
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Table 11 contains data for kidney tissue.

The vitamin treated

groups were not statistically different in inorganic and total mercury
concentrations compared to controls.

The 812/folate and vitamin C

groups had significantly more inorganic and total mercury than the all
vitamin group.

Additionally, methylmercury concentration in the

812/folate group (16.92 µg) was significantly higher than controls
(14.72 µg) and the all vitamin (13.46 µg), 812/vitamin C (14.11 µg) and
folate/ vitamin C (14.77 µg) groups.

The all vitamin group had the

lowest mercury concentrations of all groups while the 812/folate group
had the highest concentrations.

Percent methyl values in the B12 and

folate groups (46% and 45% respectively) were significantly higher than
controls (43%).
In hair tissue (Table 12), inorganic mercury concentration did not
differ among the groups.

Both the folate group and vitamin C group had

methyl and total mercury concentrations which were significantly higher
than controls.

Of interest also was the fact that the folate group had

significantly more methyl and total mercury than the all vitamin and
B12/folate groups.

While the vitamin treated groups all tended to have

higher percent methylmercury levels than controls, only the folate group
(60%) was significantly higher than controls (45%) and the 812/folate
group (47%).
The data for the blood sample are shown in Table 13.

Inorganic

mercury data indicated that the vitamin C group (.28 µg) was
significantly higher than the 812/folate group (.18 µg) but these groups
were not different from controls.

Methylmercury concentration in the

folate group (.13 µg) was significantly lower than controls (.18 µg).
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For total mercury concentration, only the vitamin C group (.44 µg) was
significantly different than the B12/folate group (.35 µg) and folate
group (.33 µg).

The three groups treated with individual vitamins all

had percent methylmercury values which were significantly lower than the
controls and B12/folate group.
Rats Treated With Cysteine or Methionine
Six tissues were analyzed in rats to examine the effect of cysteine
or methionine supplemented diet regimes on mercury metabolism.

These

data were compared to control animals fed a normal dietary regime.

The

results of this experiment are shown in Tables 14 - 19.
The data from the liver tissue are shown in Table 14.

There was a

general trend for the methionine group to have the lowest concentrations
of all three forms of mercury.

For example, the methionine group had an

inorganic mercury level of 1.39 µg compared to the controls (2.02 µg)
and the cysteine group (1.89 µg).

Methylmercury measurements were .79

µg for the methionine group, .92 µg for controls, and 1.07 µg for the

cysteine group while total mercury levels were 2.18 µg, 2.93 µg, and
2.96 µg for the methionine, controls and cysteine groups, respectively.
However, these differences were not statistically different from control
animals.

Both the methionine and cysteine groups exhibited percent

methyl values which were significantly higher than controls (36% for
both vs 32% for controls).
In brain tissue neither mercury concentration or percent mercury
did not differ for the methionine and cysteine groups from controls.
Inorganic mercury data were very similar while the methyl and total
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Table 14.

Mercury Levels in the Liver Tissue of Rats with Methionine or Cysteine Supplemented Diets

ug Hg/g wet tissue
Meth~l Hg

Total Hg

Inorganic

Treatment

Inorganic Hg

Controls
n=5

2.02 ± .68a

.92 ± .21a

2.93 ± .89a

68a

32a

Methionine
n=5

1.39 ± .1sa

. 79 ± .11 a

2 .18 ± . 26a

64b

36b

Cysteine
n=5

1. 89 ± . 71 a

1.07 ± .33a

2. 96 ± 1. 03a

64b

36b

%

% Meth~l

........
(.J'1

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 15.

Mercury Levels in the Brain Tissue of Rats with Methionine or Cysteine Supplemented Diets

ug Hg/g weLtissue
Treatment

-...J
O'\

Inorganic Hg

Meth:il Hg

Total Hg

% Inorganic

% Meth:il

Controls
n=5

.35 ± .o6a

.27 ± .o5a

.62 ± .oga

56a

44a

Methionine
n=5

.36 ± .o5a

.30 ± .o6a

.67 ± .01a

55a

45a

Cysteine
n=5

.36

.32 ± .o5a

.67 ± .oga

53a

47a

.01a

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 16.

Mercury Levels in the Lung Tissue of Rats with Methionine or Cysteine Supplemented Diets

µg Hg/g wet tissue
. Treatment

-...J
-...J

Inorganic Hg

Meth~l Hg

Total Hg

% Inorganic

% Meth~l

Controls
n=5

. 65 ± .18a

.39 ± .oaa

1.04 ± .25a

62a

39a

Methionine
n=5

.67 ± .11a

.43 ± .oaa

1.10 ± .19a

61a

39a

Cysteine
n=5

.64 ± .o5a

.40 ± .o3a

1.03 ± .o6a

62a

39a

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 17.

Mercury Levels in the Heart Tissue of Rats with Methionine or Cysteine Supplemented Diets

µg Hg/g wet tissue
Treatment

Inorganic Hg

Meth~l Hg

Total Hg

% Inorganic

% Meth~l

Controls
n=5

. 52 ± .10a

.30 ± .01a

.82 ± .14a

54a

35a

Methionine
n=5

. 53 ± .10a

.34 ± .o6a

.86 ± .15a

61a

39a

Cysteine
n=5

.51 ± .12a

.34 ± .o5a

.85 ± .17a

59a

41a

.......

co

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

Table 18.

Mercury Levels in the Spleen Tissue of Rats with Methionine or Cysteine Supplemented Diets

µg Hg/g wet tissue
Treatment

Inorganic Hg

Controls
n=5

1.74 ± .36a

Methionine
n=5
Cysteine
n=5

Total Hg

% Inorganic

. 99 ± .18a

2.73 ± .s1a

54a

35a

1. 36 ± • 29a

.86 ± .22a

2.22 ± .49a

61a

39a

1. 53 ± .1 sa

1.01 ± .01a

2.54 ± .19a

60a

40a

Meth~l Hg

% Meth~l

'-J

\.0

Values represent the average± S.D.
significantly different {p > 0.05).

Data sharing a common subscript letter in a column are not

Table 19.

Mercury Levels in the Kidney Tissue of Rats with Methionine or Cysteine Supplemented Diets

µg Hg/g wet tissue
Treatment

Inorganic Hg

Methyl Hg

Total Hg

% Inorganic

% Methyl

Controls
n=5

18.70 ± 2.11a

14. 84 ± 1. 20a

33.54 ± 3.34a

55a

44a

Methionine
n=5

17.31 ± 1.73a

14.38 ± 1.33a

31.69 ± 3.o5a

55b

45b

Cysteine
n=5

16.89 ± 1. 10a

14.19 ± 1.42a

31. 08 ± 3 . 11 a

55b

45b

CX)

0

Values represent the average± S.D.
significantly different (p > 0.05).

Data sharing a common subscript letter in a column are not

mercury measurements were slightly higher in the two treatment groups
compared to controls.

Also, percent methyl was highest in the cysteine

group (47%) compared to the controls (44%) and methionine groups (45%).
There were no differences between controls and the two treatment
groups in the lungs for mercury concentrations or percent mercury.

The

methionine group did have the highest concentration values of all three
groups.
In heart tissue there were also no statistical differences in
concentrations or percent mercury between groups.

Again, the methionine

group tended to exhibit the highest concentration values, yet the
cysteine group had the highest percent methylmercury (41%) compared to
controls (36%) and the methionine group (39%).
In spleen tissue mercury concentrations and percent mercury were
not statistically different for any of the groups.

In fact, the

concentration data from this tissue were very similar to the liver.

The

methionine group had the lowest values with inorganic at 1.36 µg, methyl
at .86 µg, and total mercury at 2.22 µg.

This compared to control

inorganic mercury of 1.74 µg, methyl .99 µg, and total 2.73 µg, with the
cysteine group having 1.53 µg inorganic, 1.01 µg methyl, and 2.54 µg
total mercury.

Additionally, both the methionine and cysteine groups

had a higher percent methylmercury (39% and 40%, respectively) compared
to controls (36%).
The data from the kidney also showed no statistical differences in
concentrations for the three groups.

However, the methionine and

cysteine groups both tended to have lower mercury concentrations.

81

These

two groups did have percent methylmercury values which were
statistically different from the control animals.
Auditory Brainstem Response Data
The auditory brainstem response (ABR) data for controls and the
mercury treated groups by the different frequencies are shown in Tables
20-23.

The individual frequency means for each group are provided in

Appendix 2.

Guinea pigs which had been fed a control diet and had no

exposure to mercury served as the control or untreated group.
Recordings were obtained from this group and provided an example of
normal guinea pig ABR measurements.

These animals were then given

subcutaneous injections of mercuric chloride (0.6 mg/kg body weight)
every other day for a total of nine injections.
treatment, ABR recordings were obtained.

At the end of mercury

This group was designated as

the mercury only group and provided information on ABR dysfunction as a
result of inorganic mercury intoxication.

All vitamin groups received

mercury treatment and were designated according to their respective
vitamin regimes.

ABR measurements from the vitamin groups with mercury

treatment were subsequently compared to the recordings from the mercury
only group.

These data served to determine if a vitamin(s) had altered

the mercury effect as measured by ABR.
All animals exhibited a positive Preyer's reflex except for three
animals in the B12 group.

By visual inspection, the ABR measurements

for these animals correlated to the Preyer's reflex observations with
delayed latencies and increased thresholds exhibited in these animals.
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Table 20.

Auditory Brainstem Responses at 8K Frequency in Guinea Pigs with Mercury Treatment and
Various Vitamin Regimes

I Latency
{msec}

Treatment
Untreated
Controls
n;;lO
CX)

w

Controls+ Hg
n;:;5

s12 /Folate
n;:;5

I Amp 1itude
{ l! V}

II Latency
{msec}

I I Amp 1itude
{ !:!V)

V Latency
{msec}

V Amp 1 itude
{ !:!V}

1.59 ± a,b

.96 ± .s2a,b

2.43 ± .27a

.52 ± .ssa,b

3.91 ± .37a

.67 ± _54a,b

1.54 ± .2ob,c

.87 ± .51a,b

2.42 ± .24a

.51 ± _43a,b

3.95 ± .3la

.46 ± .4lc

2.41 ± .23a

.57 ± .51a,b

3.90 ± .39a

.76 ± .Goa

+ Hg 1.51 ± .2oc

1.05 ± .47a

812 + Hg
n;:;5

1.66 ± .29a

.90 ± .46a,b

2.45 ± .26a

.45 ± .34a,b

3.89 ± .32a

.77 ± .6la

Folate + Hg
n;:;5

1.52 ± .21b,c

.83 ± _44b

2.40 ± .22a

.67 ± .44a

3.86 ± .32a

.55 ± ,43b,c

Vitamin C + Hg
n;:;5

1.60 ± .2oa,b

.96 ± ,44a,b

2.38 ± .19a

.43 ± .38b

3.85 ± .37a

.76 ± .58a

-Values represent the average± S.D. for all intensities.
are not significantly different (p > 0.05).

Data sharing a common subscript letter in a column

Table 21.

co
.,i:::.

Auditory Brainstem Responses at 6K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin
Regimes

Treatment

I Latency
{msec}

I Amplitude
{µV}

Untreated
Controls
n=lO

1.68 ± .3oa b
'

.79 ± .55a

2.54 ± .3oa

.45 ± .5la

4.03 .36a,b,c

.54 ± .43a

1.67 ± .24a,b

.65 ± .32a

2.59 ± .21a

.36 ± .29a

4.12 ± ,39a,b

.29 ± ,34b

812/Folate + Hg 1.68 ± .32a,b
n=5

. 77 ± .48a

2.60 ± .3la

.52 ± .48a

4.15 ± _53a

.57 ± .45a

Controls+ Hg
n=5

II Latency
{msec}

II Amplitude
{µV}

V Latency
{msec}

V Amplitude
{l!V}

812 + Hg
n=5

1.73 ± .23a

.73 ± .42a

2.54 ± .27a

.47 ± .43a

3.96 ± .21c

.63 ± .54a

Folate + Hg
n=5

1.61 ± .22b

.68 ± .4oa

2.52 ± .26a

.54 ± .48a

3.98 ± .20b,c

.52 ± .36a

Vitamin C + Hg
n=5
--

1.71 ± .23a

.66 ± .35a

2.50 ± .25a

.35 ± .32a

3.92 ± .32c

.57 ± .45a

Values represent the average± S.D. for all intensities.
are not significantly different (p > 0.05).

Data sharing a common subscript letter in a column

Table 22.

Auditory Brainstem Responses at 4K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin
Regimes

Treatment

co

<.Tl

I Latency
{msec}

I Amplitude
{µ V}

II Latency
{msec}

I I Amplitude
{~ V}

V Latency
{msec}

V Amplitude
{~ V}

Untreated
Controls
n=lO

1.79 ± .3Ia

.92 ± .78a,b

2.64 ± .21a,b,c

.61 ± .6aa,b,c

4.18 ± .36a

.56 ± .45a

Controls+ Hg
n=5

1.75 ± .24a

.72 ± .66b,c

2.67 ± _32a,b,c

.59 ± .69a,b,c

4.20 ± .33a

.35 ± .Jab

2.67 ± .29a,b

.74 ± .86a,b

4.12 ± .27a

.64 ± .5oa

81 2/Folate + Hg 1.76 ± .2aa
n=5

1.05 ± .78a

B12 + Hg
n=5

1.90 ± .27b

.72 ± .5Ib,c

2.73 ± .3Ia

.43 ± _53c

4.12 ± .26a

.53 ± .46a,b

Folate + Hg
n;:;:5

1.77 ± .27a

.86 ± .69a,b,c

2.61 ± .25b,c

.82 ± .83a

4.10 ± .20a

.51 ± .41a,b

Vitamin C +Hg
n=5
--

1.84 ± .29a,b

.65 ± .sic

2.56 ± .24c

.so± .ssb,c

4.07 ± .3la

.52 ± _37a,b

Values represent the average± S.D. for all intensities.
are not significantly different (p > 0.05).

Data sharing a common subscript letter in a column

Table 23.

Auditory Brainstem Responses at 2K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin
Regimes

Treatment

co

"'

I Latency
{msec}

I Amp 1 itude
{ h! V}

II Latency
{msec}

I I Amp 1itude
h!V}

V Latency
{msec}

V Amp 1 itude
{!::!V}

Untreated
Controls
n=lO

2.17 ± .3la

.64 ± .4aa,b

3.06 ± .2aa

.42 ± ,53a,b

4.52 ± .36a,b

.36 ± .2aa

Controls+ Hg
n=5

2.16 ± .21a

.48 ± .42b

3.07 ± .3la

.41 ± .56a,b

4.59 ± .27a

.18 ± .13b

B12/Folate + Hg 2.08 ± .29a
N=5

.70 ± .48a

3.03 ± .29a

.52 ± ,44a,b

4.41 ± .3oa,b

.39 ± .2aa

B12 + Hg
n=5

2.30 ± ,35b

.52 ± .3aa,b

2.95 ± .3oa

.49 ± .5aa,b

4.43 ± .3oa,b

.31 ± .12a

Folate + Hg
n=5

2.11 ± .27a

.60 ± .41a,b

2.93 ± .26a

.63 ± .66a

4.46 ± .26a,b

.39 ± .26a

Vitamin C + Hg
n=5

2.20 ± .29a,b

.47 ± .26b

3.30 ± .33a

.25 ± .25b

4.37 ± .29b

. 32 ± .18a

-Values represent the average± S.D. for all intensities.
are not significantly different (p > 0.05).

Data sharing a common subscript letter in a column

At a frequency of 8k, several differences were observed.

The 812

group had a wave I latency of 1.66.msec. which was longer (p < 0.05)
than the mercury only treated group (1.54 msec.).

This increase in

latency of wave I by the 812 group as compared to the mercury only group
is depicted in Figure 5.

Waves II and V latencies showed no differences

between groups.
The amplitude of wave I was lowest for the folate group which was
different (p < 0.05) from the 812/folate group, but not the untreated
control and mercury only groups.

However, for wave II amplitude, the

measurements were opposite from wave I.

Although the folate group had

the highest wave II amplitude (.67 µV) of all the groups, it was only
statistically different from the vitamin C group (.43 µV).

The wave V

amplitude data indicated that the mercury only group had a lower (p <
0.05) amplitude than untreated controls and all the vitamin groups
except the folate group.
At a frequency of 6k, wave I latencies were not significantly
different between groups.

However, the means for the 8 12 group and

vitamin C group were longer than the mercury only treated group.

Wave

II latencies were not statistically different among the groups.

Wave V

latency data indicated that the 812 and vitamin C groups had latencies
(3.96 msec. and 3.92 msec., respectively) which were different (p <
0.05) than the mercury only group (4.12 msec.).
The amplitudes for waves I and II were not different (p < 0.05) for
all groups at the 6k frequency.

The mercury only group generally had

the lowest amplitude for these two waves and in wave V, this group had a
amplitude (.29 µV) which was lower (p < 0.05) than the untreated
87

A

B

ms

Tracings represent responses to 256 stimuli. Each
trace was performed in duplicate. Vertical scale
equal to .61 µV and horizontal to 1 msec.

Figure 5.

Latency alterations of Wave I at 8K frequency and 105 dB
intensity for mercury only (A) and B12 animal (B).
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control (.54 µV) and the vitamin treated groups.

There was a trend for

the vitamin groups treated with B12 and/or folate to exhibit higher
amplitudes compared to the mercury only group.
The B12 group had a wave I latency (1.90 msec.) that was longer (p <
0.05) than untreated controls and the mercury only group (1.79 msec.
and 1.75 msec., respectively) as well as the B12/folate group (1.76
msec.) and folate group (1.77 msec.) at a frequency of 4k.

While this

group also had the longest latency (2.73 msec.) for wave II, it was not
different (p < 0.05) from the mercury only group (2.67 msec.).

The wave

V latencies were not different (p < 0.05) among the groups; however, the
means for the vitamin treated groups were shorter for wave V latencies
than the untreated and mercury only groups.

This was similar to the 8k

frequency data for wave V latencies.
The wave I amplitude measurements for the 4k frequency indicated
that the B12/folate group had an amplitude (1.05 µV) which was higher (p
< 0.05) than the mercury only and B12 groups (.72 µV).

amplitude data showed no differences among groups.

The wave II

However, the B12

group had the lowest mean for wave II amplitude, which was different (p
< 0.05) than the 812/folate and folate groups, although not

different from the mercury only group.

It was observed that the two

folate treated groups generally had higher amplitudes than the other
groups.

For wave V amplitudes, the mercury only group (.35 µV) again

was lower (p < 0.05) than the untreated control (.56 µV) as well as the
B12/folate groups (.64 µV).

The alterations of wave amplitudes with

mercury treatment are depicted in Figure 6 which compares a untreated
control animal with a B12 treated animals.
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A

B

ms

Tracings represent responses to 256 stimuli. Each trace
was performed in duplicate. Vertical scale is equal to
.61 µV and horizontal scale equal to 1 msec.

Figure 6.

ABR wave amplitude alterations with mercury treatment in
untreated controls (A) and vitamin 812 treated (8) animal
at 4K frequency and 105 dB intensity.
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The B12 group had a wave I latency which was longer (p < 0.05) than
all other groups except the vitamin C group at the 2k frequency.
However, the wave II latencies were not different (p < 0.05) between the
various groups.

The vitamin C group had a wave V latency (4.37 msec.)

which was shorter {p < 0.05) than the mercury only group (4.59 msec.).
Again, the means of the vitamin groups for wave V latencies were shorter
than untreated controls and mercury only animals.
The B12/folate group had a wave I amplitude (.70 µV) which was
significantly higher than the mercury only group (.48 µV).

The wave II

amplitude data yielded no differences between the mercury only group and
remaining groups.

Once again, the wave V amplitude was most affected in

the mercury only group, which was significantly lower (.18 µV) than the
control and other treated groups.
The data for the interpeak latencies (IPL) are shown in Table 24.
The B12 group had IPL's which were shorter (p < 0.05) than controls and
mercury only treated animals at Bk, 4k, and 2k frequencies.

This

group's IPL were also significantly shorter than the mercury only group
at the 6k frequency.

In addition, the B12 group exhibited IPL's which

were shorter (p < 0.05) than the B12/folate group at all frequencies.
Interpeak latencies in the vitamin C group were significantly shorter
than all the other groups except the 812 group for all frequencies.

In

the 6k frequency, IPL's for the mercury only group (2.47 msec.) were
longer {p < 0.05) than the untreated controls (2.35 msec.).
In Table 25 the threshold data are presented.

The B12 group had

thresholds which were higher (p < 0.05) at Bk (70.0 dB) compared to the
control (51.5 dB), mercury only (56.0 dB), and B12/folate (56.0 dB)
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Table 24.

1-V Interpeak Latencies for ABR's at Various Frequencies in
Guinea Pigs with Mercury Treatment and Various Vitamin
Regimes

2K

SK

6K

4K

Treatment

(msec)

(msec)

{msec)

(msec)

Untreated
Controls
n=lO

2.34a,b

2.3sa,b

2.4oa,b

2.36a

Controls+ Hg
n=S

2.42a

2.47c,d

2.46a

2.43a

812/Folate + Hg
n=S

2.4oa

2.49d

2.37a,b

2.33a

812 + Hg
n=S

2.24c

2.26b,e

2.24c

2.0gb

Folate + Hg

2.37a

2.37a,c

2.35b

2.37a

2.26b,c

2.22e

2.2sc

2 .17b

n=S

Vitamin C + Hg
n=S

Values represent the average for each group. Data sharing a
common subscript letter in a column are not significantly different
(p > 0.05).
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Table 25.

Threshold Values for ABR's at Various Frequencies in Guinea
Pigs with Mercury Treatment and Various Vitamin Regimes

8K
(dB}

6K
(dB}

4K
(dB}

2K
(dB}

Untreated
Controls
n=IO

51.5 ± 3.4a

58.5 ± 6.7a

57.0 ± 5.9a

69.0 ± 4.6a,b

Controls + Hg
n=5

56.0 ± 2.2a

61.0 ± 4.2a,b

60.0 ± 3.sa,b

75.0 ± 7.1a,b

812/Folate + Hg
n=5

55.0 ± o.oa

60.0 ± 3.5a,b

53.0 ± 2.7a

66.0 ± 2.2b

812 + Hg
n=5

70.0 ± 16.2b

73.0 ± 17.9b

69.0 ± 17. 1b

77 .0 ± 12.sa

Folate + Hg
n=5

62.0 ± 5 . 7a,b

66.0 ± 13_ 9a,b

60.0 ± 11.7a,b

74.0 ± 9. 5a' b .

Vitamin C + Hg
n=5

60.0 ± 3_5a,b

62.0 ± 5.7a,b

59.0 ± 4.2a,b

75.0 ± 7.1a,b

GrOUQS

Values represent the average± S.D. for a11 intensities. Data sharing a common
subscript letter in a column are not significantly different (p > 0.05).
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groups.

Additionally, the 812 group had the highest thresholds at all

frequencies compared to the remaining groups.

Of particular interest is

the fact that the 812 group had significantly higher thresholds than the
812/folate group at the Bk, 4k and 2k frequencies.

It also should be

noted that at the 4k and 2k frequencies all the mercury treated groups
had higher thresholds than the untreated control animals except the
81/fo late group.
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CHAPTER V
DISCUSSION
Mercury concentrations appeared to be lowered with the all vitamin
treatment compared to controls in all tissues except for the heart and
lungs while percent methyl mercury was increased.

It is possible that

with all three vitamins present at megadoses, these animals were able to
detoxicate and excrete mercury more efficiently.

It has been shown that

bacteria and yeasts can detoxicate metallic mercury by first methylating
it and then, demethylating it to elemental mercury, possibly by going
through the mercurous form (110).

It has been suggested that this

biotransformation may also occur in humans, but the exact mechanism
remains unclear (87).

Therefore, since methylation possibly is the

first step in the detoxication process, the animals with the all vitamin
treatment may have been able to quickly methylate the mercuric chloride
which is reflected in the increase in percent methylmercury values.

The

methylmercury was then further detoxicated and removed from the tissues,
thus, leaving decreased tissue concentrations.

The higher mercury

concentrations in the lungs and heart with the all vitamin treatment may
represent blood concentrations i.e.

transport through the body for

excretion.
The next step in this investigation was to determine which
vitamin(s) were playing a role in mercury metabolism.

The 812/folate

and 812/vitamin C groups seemed to exhibit the most activity in terms of
methylmercury concentration and percent methylmercury.

When compared to

control animals, the B12/folate group had a higher methylmercury
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concentration in the liver, kidney and hair and this difference was
statistically significant in the liver and kidney.

Additionally, an

increased percent methylmercury content in all the tissues analyzed was
observed in the 812/folate group when compared to controls, but this
difference was only significant in the liver and heart.

The 812/folate

and 812/vitamin C groups both had the highest percent methylmercury
values of all the groups in the muscle and brain.

In fact, the

812/vitamin C group was significantly higher than controls in the brain.
It would appear that the two 812 combination groups (i.e.

812/folate,

812/vitamin C) were similar to the all vitamin treated group in
explaining the percent methylmercury data for the various tissues.
Therefore, 812 apparently is the most important (the common denominator)
vitamin in terms of increasing the percent methylmercury levels.
Another interesting concept is evident from these data.

The

folate/vitamin C group exhibited an increase in mercury concentration
(both inorganic and methyl) in the muscle and heart.

The folate and

vitamin Conly groups had increased concentrations in the lungs.
Therefore, as observed in the all vitamin treatment group, folate and/or
vitamin C appear to be the vitamins involved in increasing mercury
concentrations in the heart and lung tissues.

Also of interest with the

vitamin combination groups, was the tendency for methylmercury to
decrease proportionately even though the concentrations increased.

This

was also similar to the all vitamin group data.
In order to isolate the specific vitamin activities in the various
tissues, the vitamins were given separately.

An increase in mercury

concentrations was observed in the liver and spleen for all the
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individual vitamins, but vitamin C exhibited the highest inorganic
mercury values in these tissues compared to all the vitamin treated
groups.

Of particular interest was an increase in methylmercury

concentration for the individual vitamin groups in the spleen, kidney,
and hair.

Also, with the individual vitamins, the percent methylmercury

increased in the liver, kidney, and hair, but decreased in the muscle,
brain, heart, lung, spleen, and blood.

Of those tissues which exhibited

an increase in percent methylmercury, the folate group showed the
highest elevation in the liver and hair while the B12 group showed the
highest elevation in the kidney.

Furthermore, in those tissues with a

decrease in percent methylmercury, the vitamin C group was lower (p <
0.05) than controls in percent methylmercury in the muscle and blood.
Therefore, it would again appear that 812 and/or folate play a role in
methylation of mercury, while vitamin C may affect the increase in
mercury concentrations, particularly inorganic mercury, and thus, result
in a decrease in percent methylmercury.
As these data began to accumulate, there were several tissues which
presented unique information.

First of all, the liver may be the most

significant tissue in terms of the methylation process and eventual
excretion.

It possibly is the organ where the inorganic mercury is

methylated and then "shipped out" for excretion.

It has been proposed

(64,87,110) that the methylation process is enzymatic and certainly the
liver would be rich in enzyme systems.

Also, as reported by Alexander

and Aaseth (34), methylmercury apparently is transported from the liver
to the kidney attached to glutathione.

Since the liver is able to

synthesize glutathione, it would support this concept of methylation and
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excretion.

When all the vitamins were given together, the liver's

ability to methylate mercury was enhanced with subsequent export to the
kidneys for excretion, thus, the mercury concentrations declined in the
various tissues.

Additionally, an increase in percent methylmercury was

observed in most of the vitamin groups as compared to controls.

This

phenemenon may indicate that the liver is a site of methylation, but
without all the vitamins present the process is slowed.
The three groups treated with the individual vitamins had increased
mercury concentrations.

A possible explanation for this is that mercury

accumulated due to the liver's inability to methylate it quickly and
thus, get rid of it.

This inability possibly is because all the

necessary vitamins were not available at appropriate levels.
The brain was an important tissue to investigate in this study
since only the methylated form of mercury is able to cross the
blood-brain barrier.

Vitamin combinations which included B12 appeared

to be the most effective in altering the percent methylmercury content
in this tissue.

Particularily significant is the B12/vitamin C group

activity, which displayed the greatest increase in methylmercury
concentration and percent methylmercury.

This gives rise to an

intriguing concept.

Vitamin B12 and C may be acting synergistically in

mercury metabolism.

Hypothetically, vitamin C may in some way reduce

the Co+3 to Co+2 so that folate is able to re-methylate the B12 by
donating a free radical methyl (CH 3 .).

The additional electron enables

a carbanion (CH 3-) to be released from 812 in order to methylate mercury.
The 812 only group did not exhibit the same trends as the B12 combination
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groups which may be due to a lack of contributing vitamins to
re-methylate 812 •
Hair tissue has long been recognized as an excellent indicator of
methylmercury levels in the body.

This is due to the sulfur containing

protein, keratin, found in hair which readily binds to methylated
mercury {13).

Accordingly, the hair data from all the animals treated

with vitamins seemed to support this concept.

In each case the

concentration and percent methylmercury increased with dietary intake of
vitamins.
only.
group.

The greatest increase occurred in those animals given folate

This is similar to the data in the liver for the folate only
Consequently, folate must be playing a role in the methylation

of mercury either in combination with vitamin 812 or alone.
As reported previously, folate {N 5 -methyltetrahydrofolate) can
contribute a free radical methyl group to 812 {Co+2).

However, this

form of 812 theoretically cannot methylate mercury which requires a
carbanion ion.

As suggested earlier, vitamin C may act synergistically

with 812 and folate resulting in the release of a carbanion from 812 and
subsequent methylation of mercury.
deficient in any vitamin.

None of the diets in this study were

Therefore, the folate group may have had

sufficient levels of 812 and/or vitamin C to methylate the mercury and
rapidly regenerate the proper form of 812 • Thi~ resulted in the high
level of methylation exhibited in hair.
Another hypothesis is proposed to explain the unexpected results
displayed by the folate treated groups in this investigation.

It may be

possible that folate {N 5 -methyltetrahydrofolate) can contribute a
carbanion {CH3-) and methylate mercury.
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For example, the N5 -methyl THF

becomes desaturated at the 5,6 bond which results in the release of a
carbanion group and the formation of dihydrofolate.

This reaction is

similar to that which occurs in thymidylate synthesis due to the
activity of thymidylate synthetase.

This would certainly explain the

high level of methylated mercury which resulted in folate treated
animals in the liver and hair.

It may also be the reason for the high

mercury concentrations observed in the muscle with folate/vitamin C
treatment.
Animals treated with vitamin C and/or some combination displayed
conflicting data.

Treatment with vitamin C by itself resulted in

increased mercury concentrations, particularily inorganic, in the liver,
spleen, kidney, hair and blood compared to controls.

In muscle, the

folate/vitamin C group had statistically significant increased mercury
concentrations, while in the brain the B12/vitamin C group exhibited
A recent report {111) showed that

increased levels of methylmercury.

the cupric {Cu++) form of copper was an efficient catalyst of ascorbate
oxidation.

It was suggested that in the presence of any transition

metal, the oxidation of ascorbate can occur.

Therefore, the mercuric

ion may effectively oxidize ascorbate resulting in the reduction of
mercury to the mercurous {Hg+) form.

In this form, a free radical

methyl group could bind to the mercury.
could methylate the metal.
toxic to mammals.

This implies that N5 -methyl THF

Also, the mercurous form is known to be less

In fact, mercurous has been used in the past by

humans as a laxative and diuretic {112).

This may explain the increased

levels of inorganic mercury in certain tissues with vitamin C treatment
or some combination thereof.
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The muscle tissue provided data which indicated that the all
vitamin or vitamin combination treatments resulted in an increase in
percent methylmercury.

With the exception of the folate/vitamin C

group, the mercury concentrations were low and consistent among the
Yet, there was an obvious increase in the percent

various groups.

methylmercury with vitamin treatment except in the individual vitamin
groups.

Methylmercury is lipid soluble and therefore, is more likely to

be associated with lipid substances in the body.

Since the muscle

samples were not devoid of lipid, these data may be a reflection of
lipid storage of mercury in the guinea pig.
The heart, lungs, and spleen tissues generally provided data which
may be influenced by the high degree of blood perfusion through these
organs.

The levels of mercury varied according to treatment and tissue

but may reflect the ability of the tissue to concentrate mercury.

The

percent mercury data for the vitamin treated groups were consistent with
or slightly lower than controls, except in the heart where the
812/folate group was higher.

However, this group had increased

methylmercury in the liver, muscle, kidney, and hair.

So the heart data

may simply reflect the blood transport from or to these tissues in the
treated animals.
Since the kidney is an excretory organ, the data from this tissue
would indicate the accumulation of mercury for excretion.

The mercury

concentration in the kidney was approximately 10-20 times higher than in
any other tissue.

It would be informative to measure urine excretion of

mercury in order to determine the maximum clearance rate of mercury in
these animals.

However, in this investigation, it appears that the
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kidneys did not lose their ability to concentrate mercury and thus, it
is assumed the dose level of mercury given in this study was
appropriate.
ABR Testing
The auditory brainstem response testing was performed in two groups
of vitamin and mercury treated guinea pigs.

Prior to mercury exposure,

the control animals were tested to establish normal data.
The ABR testing served two functions in this study.

Thus far, no

research has been done to investigate the effect of inorganic mercury
treatment on guinea pig ABR.

Therefore, this study was the first to

examine the effect of inorganic mercury intoxication on the auditory
system as evaluated by ABR data.

Mercury treatment may result in

peripheral damage and/or CNS alterations.

Evidence has been presented

to indicate damage by mercuric chloride to the sensory epithelium in the
apical area (low frequency) of the guinea pig cochlea (113) and it has
been shown to damage the mitochondria in hair cells and nerve terminals,
which in turn results in impaired mitochondrial function, i.e.
oxidative phosphorylation, calcium transport and phosphate accumulation
was suppressed while ATP hydrolysis, potassium and magnesium transport
were induced (114).

Therefore, the mercuric chloride interferes with

cell respiration and ATP synthesis which would delay signal
transmission.

However, in the present study, wave latencies across

frequencies were not different for the mercury only treated animals
compared to untreated controls.

Thus, a large number of fast

conducting, large diameter fibers have not been affected by mercury
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treatment.

In addition, IPL's were not significantly different in these

two groups.

This would suggest that impulse conduction time in the

lower auditory centers and CNS has not been altered by inorganic mercury
treatment regardless of frequency.
However, treatment with inorganic mercury (mercury only group)
resulted in a decrease in all wave amplitudes compared to untreated
controls.

This group exhibited a significantly lower wave V amplitude

at all frequencies compared to untreated controls.

Wave amplitude data

are difficult to interpret due to the extreme variability among animal
species.

However, alterations in wave amplitudes can be due to damage

of the peripheral or CNS auditory systems.

If the damage occurs within

the brainstem areas of the auditory system, it would be due to
methylmercury toxicity since this is the only form of mercury which can
cross the blood brain barrier.

These animals were not deficient in any

vitamin and thus, these data may simply represent a normal methylation
process of inorganic mercury and subsequent transport into the.CNS.
In order to determine if the decrease in wave amplitude was due to
methylmercury damage of the auditory centers within the brainstem, the
IPL data were examined.

Research has demonstrated that methylmercury

exposure results in shorter interpeak latencies (61).

Yet, in the study

reported here, the mercury only group exhibited IPL means which were
longer than untreated controls.

Furthermore, the wave V latency means

for the mercury only group were longer than untreated controls while
wave I latencies means were uneffected or slightly shorter than
untreated controls.

While these differences were not statistically

significant, damage within the brainstem is indicated which supports the
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concept that the inorganic mercury has been converted to methylmercury.
Damage of the larger diameter or faster conducting fibers would result
in longer interpeak latency values.

Therefore, the decrease in wave

amplitudes observed in mercury only treated animals would be due to
signal transmission through the slower, small diameter fibers resulting
in a decrease in nerve signal strength.

Wave amplitudes can also be reduced when peripheral damage has
occurred.

Again, damage to the larger fibers would result in signal

transmission through the smaller diameter fibers, and thus, a decrease
in the strength of the action potential.

Both inorganic mercury and

methylmercury have been shown to cause damage to the cochlea hair cells
and/or cochlear nerve.

Thus, the data generated from the present

investigation requires further research to determine the exact
structures which are effected by the different forms of mercury.
Second, this research appears to support the theory that vitamin
B12 treatment may potentiate the mercury effect, particularily in the
peripheral auditory system.

The B12 only group had the greatest

increase in wave I latency at every frequency for all groups tested.
This group exhibited a significantly longer wave I latency at 8k, 4k,
and 2k frequencies than the mercury only treated group.

Since the other

mercury treated groups were not statistically different from the mercury
only group at each frequency, B12 appears to potentiate the mercury
effects in the cochlea and/or cochlear nerve possibly due to its role in
the methylation of mercury.
According to the original hypothesis of this investigation, B12
treatment should result in increased methylation of inorganic mercury.
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With increased amounts of methylmercury available, the increased
latencies may represent degeneration of hair cells in the base of the
cochlea which has been demonstrated with methylmercury exposure (115).
Methylmercury has also been shown to result in loss of cochlear
microphonics and whole nerve action potentials (116) and this would be
demonstrated by prolonged latencies in A8R testing.

It has also been

hypothesized that methylmercury exposure results in demyelination in the
auditory nerve (57).

Damage to the large fibers in the auditory nerve

would impair rapid transients and result in longer wave I latencies.
Therefore, the delayed latencies reported here indicates damage to the
cochlea and/or cochlear nerve but the exact nature of the damage remains
elusive.
The idea that peripheral damage occurred due to increased
methylmercury levels with 812 is supported by the threshold data.

While

all the mercury treated groups tended to exhibit an increase in
threshold values compared to untreated controls, the 812 group produced
the greatest increase in threshold intensity at all frequencies.

The

812 group had significantly higher threshold values than the untreated
controls and mercury only group at the Bk frequency.

These data

indicate a high-frequency loss which would result from damage to the
basilar membrane at the base of the cochlea.
As noted earlier, mercuric chloride has been shown to result in
damage to the apex area of the basilar membrane which would be
demonstrated by a low frequency loss (57,58).

Furthermore, research

using methylmercury has shown a high frequency loss in mice (61).
suggests frequency-specific deficits to the lower auditory pathway
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This

possibly due to the type of mercury.

In this investigation, the high

frequency loss would indicate damage due to methylmercury exposure.
This possible nerve damage and subsequent increase in threshold value
observed at the 8k frequency also supports research on high-frequency
sensorineural deafness reported in 80% of the patients with
methylmercury poisoning at Minamata Bay in the 1950's (117).
B12/folate treatment did not appear to effect the wave I latencies,
which is not consistent with the B12 group data.

However, the

B12/folate group did increase the amplitude of wave I at the 8k, 4k, and
2k frequencies.

Also this group and the folate group

exhibited the greatest increase in amplitudes of wave II at all
frequencies but these differences were not significant compared to
untreated controls and the mercury only group.

This alteration in wave

amplitude certainly suggests that CNS function has been effected by
these treatments.

However, further analysis is necessary to establish

if the wave latency (i.e.

area under the specific wave) remains

constant with each treatment.

But, a decrease in wave amplitude would

normally be expected if damage to the higher auditory centers within the
brainstem has occurred.

These data demonstrated an increase in

amplitude which is difficult to explain.
The possibility exists that with B12/folate treatment, an increased
amount of methylmercury is produced.

Methylmercury may cause impairment

of slow conducting, small diameter fibers.

This would result in a

majority of transmission occurring from fast conducting, large diameter
fibers, thus, the reduced dispersement of these fibers may produce a
stronger impulse which may be demonstrated by elevated wave amplitudes.
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Inspection of interpeak latencies values revealed shortened
latencies for the B12 and vitamin C groups compared to the mercury only
group.

A probable explanation for these data can be obtained by

examining latencies for waves I and V.

The wave I latency means for

these two groups were longer than the mercury only treated group at all
frequencies.

In addition, these groups exhibited wave V latency means

which were shorter than the mercury only group.

However, upon further

inspection of the wave V latencies, it becomes apparent that the
decrease in IPL's with vitamin treatment compared to the mercury only
group is due to an increase in latency with mercury treatment.

The

vitamin treated groups exhibited wave V latency values which were very
similar to the untreated controls.

Therefore, this evidence clearly

indicates that the increase in IPL with B12 and vitamin C treatment is
due to a shift in wave I latency rather than an affect on nerve
processes which regulate nerve conduction velocity in the CNS.

The data

from the 812 group can again be explained due to its role in methylation
of mercury; however, an explanation for the vitamin C data remains
unclear.

It would appear that vitamin C potentiates the mercury affect

in the auditory nerve possibly due to its oxidation/reduction potential.
Methionine and Cvsteine Supplementation in Rats
Since investigation of methylation processes of inorganic mercury
was the intent of this research, a study was conducted in rats to
examine the possible role of methionine as a methyl donor via Sadenosylmethionine (SAM) transfer.
clarification.

Several points require

First, SAM donates a carbonium (CH3+) group which
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theoretically would not be the methyl form accepted by mercury (Hg++).
However, SAM is involved in the regeneration of cobalt (Co+2) in B12 in
those instances when the B12 becomes oxidized.

Due to its role in B12

metabolism, it would seem important to investigate SAM's effect on
mercury methylation.

Second, rats are able to synthesize vitamin C

(118) and as demonstrated in the guinea pig data, vitamin C may play a
role in mercury metabolism.

In addition, these animals were given a

diet sufficient in all vitamins including folate and B12 • Thus, rats
may be able to alter the methylation of mercury due to their ability to
make vitamin C available, as well as having sufficient dietary folate
and B12 • Third, cysteine has been shown to result in decreased SAM
concentrations in the rat liver (119).

Also, a methionine-sparing

effect has been demonstrated with cysteine supplementation (120).
Therefore, a cysteine supplemented dietary regime was included in this
study.
The methionine treated group exhibited the lowest mercury
concentrations of all three groups in the liver and spleen while having
the highest concentrations in the lungs and heart.

While there was an

apparent increase in percent methylmercury in all tissues with
methionine treatment compared to controls, this was only statistically
different in the liver and kidneys.

These data are very similar to the

guinea pigs in the all vitamin group.

It, again, raises the question

that these animals can detoxicate the mercury more readily and excrete
it from the body.

Thus, the lowered concentrations are seen.

Also,

these data suggest that methionine is altering the mercury methylation
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process since an increase in percent methyl is observed.

This possibly

is due to methionine's role in regenerating 812 •
Those animals given the cysteine supplemented diets presented data
which were slightly more complex.

Assuming that cysteine can lower the

liver concentration of SAM, it seems that these animals would exhibit a
decrease in methylation potential.

Yet, this group demonstrated the

highest methylmercury concentrations in the liver, brain, and spleen as
well as the highest percent methylmercury levels in the brain, heart,
and spleen as compared to both the control and methionine treated
groups.

However, the cysteine group exhibited percent methylmercury

values similar to the methionine group in the liver and kidneys which
were the only measurements statistically different from controls.

These

data suggest that cysteine may also play a role in mercury methylation.
A recent report {121) has shown that brain uptake of methylmercury
is enhanced by chronic L-cysteine infusion.

It was suggested that the

translocation of methylmercury across the blood-brain barrier may be
mediated by a neutral amino acid carrier transport system {121).

In the

present study, the cysteine treated group did exhibit a higher
concentration of methylmercury in the brain tissue which may lend
support to this theory.

Another possible explanation for the results

shown in the cysteine treated group is the oxidation/reduction theory
suggested for the vitamin C treated groups.

Cysteine is also easily

oxidized and, in fact, prefers the oxidized state.

Consequently,

mercury exposure may result in the oxidation of cysteine and the
reduction of mercuric to mercurous.

As suggested earlier, the mercurous

form is not as toxic to mammals or it may be methylated by
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N5 -methyltetrahydrofolate since it can accept a free radical methyl
group.

Certainly, this requires further research to elucidate the role

of cysteine in the methylation of mercury.
In conclusion, the results presented here generally support the
concept that dietary intake of megadoses of vitamin 812 , folate, and/or
vitamin C can alter the methylation, i.e.
mercury.

metabolism of inorganic

While ingestion of megadoses of all three vitamins resulted in

decreased mercury concentrations in all tissues except heart and lung,
individual vitamins or a combination of vitamins consumed in megadoses
resulted in increased methylmercury concentrations.

Furthermore, the

ABR testing provided additional evidence that mercury can result in
neurological alterations and these can be influenced by a dietary
vitamin intake.

In addition, dietary supplementation with the sulfur

containing amino acids, methionine and cysteine, may effect this
methylation process.
Factors which can alter the methylation process of mercury in vivo
may have practical significance.

For instance, in those geographical

areas where there is a relatively high consumption of foods contaminated
by mercury, the toxic effects of mercury ingestion may be significantly
enhanced in those individuals who supplement their diets with vitamins.
In addition, those individuals in the dental profession who may be
frequently exposed to mercury compounds used in dental amalgams should
become aware of the possibility that megavitamin consumption may
potentiate the methylation process of mercury.

Thus, further research

is needed in this area and dissemination of this information via
educational programs is necessary.
110

CHAPTER VI
SUMMARY
Ingestion of megadoses of certain vitamins appears to influence the
methylation of mercuric chloride in vivo.

The increased concentration

of methylmercury and percent methylmercury values exhibited in the brain
tissue with dietary consumption of vitamin 812 supports the hypothesis
that this vitamin is involved in methylating mercury and, thus, allowing
the transport of methylmercury across the blood-brain barrier.

In

addition, auditory brainstem response measurements showed that 812
treated animals displayed delayed wave I latencies and higher threshold
values compared to untreated controls and mercury only animals.

This

again suggests that this vitamin effects the methylation process.
The incorporation of high levels of folate into the diet also
influences mercury methylation.

Folate treated animals tended to have

increased concentrations of both inorganic and methylmercury,
particularly in the muscle tissue.

Animals given 812/folate and

mercuric chloride also exhibited increased A8R wave amplitudes at the
lower frequencies compared to the mercury only group.

Further research

is needed to determine the exact mechanism involved by which folate is
able to methylate mercury.
The addition of vitamin C in the diet, particularly in combination
with 812 and/or folate, resulted in increased methylmercury levels and
percent methylmercury values in the muscle, brain, and hair.

An

apparent synergistic effect was observed with vitamin C and the other
vitamins.

It has been suggested that vitamin C may play a role in the
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re-methylation process of B12 by donating an electron to the methyl
group contributed by folate.

Alternately, the mercuric form of mercury

may oxidize vitamin C and be subsequently reduced to the mercurous ion.
This form is less toxic but may also be methylated by folate eliminating
the involvement of B12 •
information.

The vitamin C group provided interesting ABR

This group exhibited higher threshold measurements

compared to controls and interpeak latencies were significantly shorter
with vitamin C treatment.

Certainly, further work is necessary to

examine these possible interactions.
And finally, diets supplemented with the amino acids cysteine and
methionine indicated that these nutrients may also be involved in the
methylation process of mercury.

The increase in percent methylmercury

levels found in the hepatic and renal tissues of rats is possibly due to
the role of methionine in various methylation activities via Sadenosylmethionine.

Contrary to the research which has shown that

cysteine inhibits certain reactions involving SAM, the animals treated
with cysteine exhibited increased percent methyl levels in the liver,
brain, heart, spleen and kidney tissues.

Therefore, it would appear

that cysteine effects mercury metabolism possibly via
oxidation/reduction reactions.

Again, this is an area requiring

additional investigation.
In conclusion, the methylation of mercuric chloride in vivo can be
increased with the ingestion of megadoses of vitamin 812 , folate, or
vitamin C.

Therefore, individuals who take large amounts of these

nutritional supplements and who ingest fish which are possibly
contaminated with industrial spills containing mercury, could have
112

increased methylmercury exposure with subsequent neurological damage.
Additionally, dental professionals should become aware of this
potential.

Further research is required to elucidate these effects and

the possible mechanisms which are involved in the methylation of mercury
in vivo.
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APPENDIXES

APPENDIX 1
Table 1-1.

Weight Data

Week

Controls

812/Folate

1

243.79 ± 17.84

242.52 ± 2.74

2

279.31 ± 33.11

290.81 ± 14.01

3

326.01 ± 32.82

356.49 ± 22.76

4

364.02 ± 41.48

393.70 ± 38.19

5

424.69 ± 49.52

441.33 ± 52.10

6

476.85 ± 54.96

481. 03 ± 73. 64

7

518.68 ± 50.79

520.61 ± 79.50

8

570.87 ± 56.03

567.09 ± 83.74

*9

610.92 ± 56.45

605.36 ± 84.93

10

633.61 ± 57.49

606.80 ± 93.90

11

540.95 ± 54.55

560.55 ± 91.14

Measurements represent the average± S.D.
*Mercury injections were begun on week #9.
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APPENDI.X 2
Table 2-1. Frequency Means for Untreated Controls by Individual
Intensities

I
Lat
(msec)

I
Amp
(µ V)

II
Lat
(msec)

105
95
85
75
65
55

1.31
1.43
1.58
1.62
1. 72
1.85

1.54
1.23
1.09
.90
.72
.28

2.13
2.25
2.37
2.51
2.59
2. 77

l. ll

105
95
85
75
65
55

1.36
1. 51
1.65
1. 74
1. 95
2 .13

1.56
.88
.68
.66
.42
.20

105
95
85
75
65
55

1.48
1.61
1. 75
1.87
2.04
2.20

105
95
85
75
65

1.87
2.01
2.15
2.37
2.51

Intensity
(dB)

V
Amp

V
Lat
(msec)

(µ V)

I-V
IPL
(msec)

.76
.47
.33
.28
.13

3.59
3.64
3.79
3.95
4.13
4.57

1.40
1.10
.69
.34
.20
.12

2.28
2.21
2.21
2.33
2.41
2.70

2.22
2.37
2.51
2.59
2.83
3.12

1.08
.59
.25
.23
.18
.09

3.79
3.81
3.91
4.06
4.33
4.62

1.16
.82
.50
.25
.15
.10

2.43
2.29
2.26
2.32
2.38
2.53

2.01
1.24
.70
.53
.46
.33

2.34
2.51
2.60
2.72
2.89
3.12

1.48
.83
.41
.19
.20
.12

4.05
4.03
4.05
4.17
4.42
4.61

1. 03
. 61
.37
.19
.14

2.57
2.42
2.30
2.30
2.39
2.51

1.25
.76
.49
.33
.23

2.80
2.88
3.08
3.26
3.52

.92
.39
.24
.26

4.41
4.34
4.39
4.66
4.93

.70
.31
.28
.25
.20

2.55
2.37
2.21
2.27
2.42

II

Amp
(µ V)

8K

6K

4K

2K

.13

127

. 77

Table 2-2.

Frequency Means for Mercury Only Animals by Individual
Intensities

Intensity
(dB}

I
Lat
(msec}

(µV)

Lat
(msec}

1.28
1.39
1.47
1.59
1. 72
1.83

1.08
1.11
1.05
.91
.65
.32

105
95
85
75
65
55

1.34
1.50
1.62
1. 73
1.85
2.03

.97
.64

105
95
85
75
65
55
105
95
85
75
65

BK

105
95
85
75
65
55

I
Amp

II

II

V

Amp

Lat
(msec}

2.12
2.23
2.36
2.47
2.62
2.79

.88
.82
.57
.39
.19
.15

.64
.67
.20

2.18
2.48
2.58
2. 71
2.82
2.88

1. 41
1.59
1. 76
1.83
1. 98
2.22

1.80
.76
.51
.42
.31
.20

3.62
3.85
3.76
3.97
4.29
4.35

.83
.86
.54
.17
.09

2.34
2.46
2.29
2.38
2.56
2.53

.85
.38
.25
.24
.19
.16

3.80
3.82
3.98
4 .10
4.52
4.77

.53
.38
.14
.27
.20
.19

2.47
2.32
2.36
2.36
2.68
2.71

2.29
2.43
2.75
2.73
2.90
3 .18

1. 79
.69
.28
.18
.24
.05

3.93
4.12
3.96
4.26
4.52
4.74

.64
.39
.47
.22
.13
.08

2.52
2.53
2.23
2.43
2.55
2.52

1.84
1. 97
2 .16
2.42
2.55

.96
.55
.37
.24
.17

2.75
2.94
3.09
3.29
3.61

1.01
.34
.24
.12
.15

4.52
4.59
4.49
4.60
4.96

.27

2.68
2.61
2.28
2 .18
2.40

4K

2K

1-V

IPL
(msec}

(µV)

6K
. 71

V

Amp
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(µV)

.11

.11

.15
.19
.12

Table 2-3.

Frequency Means for B12 Treated Animals by Individual
Intensities

Intensity
(dB)

I
Lat
(msec)

I
Amp
(µV)

II
Lat
(msec)

II
Amp
(µV)

V
Lat
(msec)

V
Amp
(µV)

I-V
IPL
(msec)

105
95
85
75
65
55

1.43
1.56
1.68
1.90
1.80
1.86

1.29
1.08
.85
.75
.52

2.23
2.37
2.55
2.50
2.75

.80
.56
.33
.30
.07

3.62
3.78
3.98
4.02
4.24

1.45
1.02
.53
.37
.12

2.20
2.22
2.30
2.12
2.44

105
95
85
75
65
55

1.54
1.67
1. 75
1.81
1. 95
2 .12

1. 21
.66
.60
.76
.41
.12

2.37
2.49
2.61
2.57
2.90

.88
.44
.17
.39
.18

3.85
3.76
4.00
4.02
4.29

1.06
.92
.43
.29
.15

2.31
2.17
2.25
2.21
2.34

105
95
85
75
65
55

1.64
1. 79
1.99
1.88
2.07
2 .18

1.27
.83
.48
.63
.49
.29

2.51
2.65
2.88
2.75
2.91
3.08

.78
.49
.24
.28
.15
.26

4.00
4.02
4.07
4.01
4.18
4.57

.86
.53
.63
.56
.22
.08

2.36
2.23
2.17
2.13
2 .11
2.39

105
95
85
75
65

2.07
2.30
2.33
2.38
2.70

.76
.58
.48
.31
.19

2.87
3.03
2.93

.69
.38
.36

4.27
4.47
4.42
4.47
4.69

.39
.34
.31
.27
.18

2.14
2.06
2.09
2.09
2.08

BK

.17

6K

4K

2K

129

Table 2-4.

Frequency Means for Folate Treated Animals by Individual
Intensities

Intensity
{dB)

I
Lat
(msec)

I
Amp
{uV)

105
95
85
75
65
55

1.28
1.38
1.48
1.61
I. 79
1.87

1.17
1.05
.93
.73

105
95
85
75
65
55

1.34
1.49
1.61
I. 76
1.88
I. 90

105
95
85
75
65
55
105
95
85
75
65

Lat
(msec)

Amp
{µV)

V
Lat
{msec)

V
Amp
(µ V)

I-V
IPL
{msec)

2.18
2.28
2.39
2.52
2.64
2.78

1.01
.97
.68
.39
.26
.12

3.57
3.67
3.80
4.02
4.37

I. 01

.86
.45
.18
.10

2.29
2.29
2.32
2.41
2.59

1.28
.73
.50
.48
.40
.24

2.25
2.37
2.50
2.70
2.86

I. 20

3.75
3.79
3.88
4.20
4.35
4.54

.93
.70
.49
.21
.09
.12

2.40
2.30
2.23
2.45
2.45
2.64

1.45
1.58
I. 70
1.83
1.99
2 .15

2.02
1.13
.55
.52

2.35
2.48
2.59
2.73
2.96
3.00

I. 93

.90
.41
.33
.25
.14

3.98
3.95
4.05
4.06
4.23
4.47

.96
.72
.47
.35
.19
.12

2.54
2.37
2.35
2.23
2.25
2.32

1.84
1.98
2.12
2.41
2.40

1.02
.79
.41
.29
.19

2.75
2.80
3.07
l.22

1.10
.89
.19
.13

4.30
4.42
4.45
4.68
4.70

.71

2.46
2.44
2.32
2.27
2.30

II

II

8K

.44

.19

6K
.69
.29
.23
.14

4K

2K

.42

.24
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.36

.26
.24
.14

Table 2-5.

Frequency Means for Vitamin C Treated Animals by Individual
Intensities

Intensity
{dB)

I
Lat
(msec)

I
Amp
(µV)

Lat
(msec)

Amp
(µV)

V
Lat
(msec)

V
Amp
(µV)

I-V
IPL
(msec)

105
95
85
75
65
55

1.33
1.46
1. 57
1.68
1.82
1. 91

1.41
1. 22
1.12
.89
.48
.15

2 .18
2.29
2.43
2.52
2.60

.79
.43
.36
.27
.12

3.50
3.60
3.75
3.93
4.30
4.72

1.48
1.22
.73
.34
.14
.12

2.17
2.14
2.18
2.25
2.48
2.74

105
95
85
75
65
55

1.42
1.59
1. 72
1.88
1.93
2.00

I.OS

.82
.64
.47
.37
.12

2.27
2.31
2.54
2.63
2.77
2.84

.59
.59
.18
.23
.14
.09

3.66
3.72
3.83
4 .16
4.35
4.20

1. 20
.89
.41
.16
.11
.09

2.24
2.13
2 .11
2.27
2.39
2.20

105
95
85
75
65
55

1.46
1.61
1.83
1. 94
2.09
2.16

1.47
.99
.52
.39
.28
.17

2.34
2.48
2.52
2.66
2.87
2.90

.85
.86
.38
.16
.10
.02

3.82
.89
3.93
4.08
4.38
4.49

.87
.92
.70
.29
.12
.08

2.36
2.28
2.10
2.13
2.32
2.33

105
95
85
75
65

1.90
2.04
2.30
2.45
2.60

.79
.56
~33
.25
.14

2.69
3.06
3.20
3.34

.46
.25
.12
.08

4.28
4.23
4.44
4.52
4.52

.47
.33
.25
.25
.12

2.37
2.17
2.14
2.02
1. 91

II

II

BK

6K

4K

2K
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Table 2-6.

Frequency Means for 812/Folate Treated Animals by
Individual Intensities

Intensity
{dB}

I
Lat
(msec}

BK

I
Amp
{µ V}

II
Lat
(msec}

II
Amp

V

1-V

Amp
(µ V}

IPL
(msec}

3.58
3.61
3. 72
3.91
4.09
4.62

1.48
1.17
.95
.45
.22
.14

2.36
2.24
2.28
2.35
2.44
2.81

V

(µV}

Lat
(msec}

1.34
.73
.61
.43
.19
.14

105
95
85
75
65
55

1.22
1.36
1.44
1.56
1.66
1.81

1.63
1.26
1.18
1.10
.33

2.12
2.23
2.30
2.44
2.63
2.74

105
95
85
75
65
55

1.32
1.48
1.59
1. 72
2.05
2.05

1.45
.81
.79
.75
.41
.20

2.23
2.40
2.50
2.64
2.92
3.08

1.31
.60
.30
.31
.30
.15

3.81
3.81
4.07
4.23
4.62
4.62

1.07
.94
.48
.28
.24
.12

2.49
2.33
2.48
2.51
2.57
2.60

105
95
85
75
65
55

1.41
1.53
1.64
1. 78
1. 96
2.22

2.43
1.29
.87
.74
.56
.40

2.32
2.44
2.56
2. 71
2.89
3 .14

2.30
1.03
.49
.28
.16
.17

3.94
3.93
3.95
4.04
4.36
4.52

1.47
.65
.76
.52
.25
.17

2.53
2.40
2.31
2.26
2.39
2.30

105
95
85
75
65

1. 76
1.89
2.05
2.24
2.48

1.32
.93
.59
.42
.23

2.76
2.84
2.98
3.20
3.61

1.07
.42
.40
.34
.27

4.36
4.19
4.31
4.48
4.86

.82
.38
.32
.27
.16

2.61
2.30
2.24
2.23
2.29

.77

6K

4K

2K
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